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ABSTRACT 
 
How neurons elaborate dendrites and axons and how they form synapses with targeted cells are 
fundamental questions in neurodevelopment. Although a number of genes have been identified 
to play a role in these processes, the following two aspects are largely unknown and interesting 
to study. First, while most genes go through alternative splicing to generate different protein 
isoforms, how each protein isoform contributes to the function of this gene in neurodevelopment 
remains a challenging question, especially at the cell-type specific and endogenous levels. 
Second, in neurodevelopmental diseases, such as those in Down syndrome, the expression levels 
of hundreds or thousands of genes are altered. The dysregulation of which gene cause the neurite 
and synaptic defects in these brain disorders remains largely unknown. My dissertation aims to 
answer these two questions with the focus of one gene, Down syndrome cell adhesion molecule 
(Dscam). 
 
Dscam is an evolutionarily conserved single-pass transmembrane protein that plays critical roles 
in multiple aspects of neuronal wiring, including dendritic/axonal growth and synapse formation. 
In Drosophila, alternative splicing of Dscam produces two mutually exclusive isoforms, 
Dscam[TM1] and [TM2], which differ in their transmembrane and juxtamembrane region. By 
developing a novel genetic method, termed isoTarget, which enables the investigation of 
isoform-specific function and endogenous localization in specific cells, I report differential 
function and localization of Dscam isoforms in axons versus dendrites. In addition, I uncovered 
 
 
x 
 
an isoform-specific signaling pathway that involves DLK/Wallenda, Dock, and Dscam[TM2], 
but not Dscam[TM1], at the axon terminals of Drosophila sensory neurons. I provide evidence 
showing that Dscam[TM2]-specific function and signaling in axon terminals are caused by its 
isoform-specific localization, rather than by biochemical differences between Dscam[TM1] and 
[TM2]. These findings not only demonstrate the specific function, localization and signaling of 
Dscam isoforms but also demonstrate the critical role of subcellular localization in expanding 
isoform diversity.  
 
In human, the Dscam gene is localized in the Down syndrome critical region on chromosome 21. 
By taking advantage of sparse neuron labeling for morphological analysis and whole-cell patch-
clamp for functional assay, I found that Dscam regulates inhibitory neuron development in the 
neocortex in a dose-dependent fashion. Loss of Dscam impairs the presynaptic growth in 
chandelier and basket cells, two major types of inhibitory neurons in the neocortex. In the 
Ts65Dn mouse model for Down syndrome, where Dscam is overexpressed, GABAergic 
inhibition of pyramidal neurons (PyNs), the main excitatory neurons in the cortex, is increased. 
Genetic normalization of Dscam expression rescues the excessive GABAergic synapse formation 
and inhibition of PyNs. These findings reveal abnormal GABAergic innervation in the neocortex 
of Down syndrome mouse model and identify Dscam overexpression as the cause. They also 
implicate dysregulated Dscam levels as a potential pathogenic driver in related neurological 
disorders. 
 
In summary, by using the novel genetic method isoTarget, this dissertation uncovers Dscam 
isoform-specific subcellular signaling cascade in neurodevelopment; using genetic normalization 
in Down syndrome mouse model, it establishes a causal effect between dysregulated Dscam 
 
 
xi 
 
expression levels and cortical defects in Down syndrome pathology. These findings are expected 
to advance our understanding of the role of Dscam in neurodevelopment and neurological 
disorders. 
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Chapter 1 
 Introduction 
 
1.1 Molecular mechanisms underlying neuronal development. 
Since Ramon y Cajal proposed more than one hundred years ago that neurons are the 
basic building blocks of the nervous system (Ramón y Cajal 1893), these specialized cells have 
fascinated scientists and the public with their highly polarized morphologies. A typical neuron 
contains three major compartments: the dendrite, cell body and axon. The dendrite is the input 
compartment that receives electrochemical signals while the axon is the output compartment for 
passing the information on to downstream cells. The axon and dendrite differ in membrane 
composition, organelle enrichment and cytoskeletal orientation, which serve as the structural 
basis for the functional distinctions of these two compartments (Yogev and Shen 2017). For 
example, synaptic vesicles are specifically localized at axon terminals. These 35- to 45-nm 
spherical vesicles contain neurotransmitters that are released upon action potentials’ arrival at the 
axon terminals (Sudhof 2012). By contrast, the small membranous protrusions, called spines, is 
only present in a neuron's dendrite. Dendritic spines receive input from single axons and convey 
electrochemical signals to the neuron's cell body (Sorra and Harris 2000) .  
To achieve such a “two-part” design, several steps are needed for neuronal development 
(Caceres, Ye, and Dotti 2012; Yogev and Shen 2017): 1) the establishment of neuronal polarity. 
A symmetry-breaking signal causes a spatial orientation in the neuron and determine the site 
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where axon/dendrite initiates. 2) Neurite extension. The dendrite and axon elongate towards their 
target areas. 3) Pre/post-synaptic development. Upon reaching the destination, the neurite 
arborizes locally and forms synapses within these arbors for synaptic transmission. Each step 
requires an exquisite orchestration of cell-intrinsic signaling cascades and the extra-cellular 
environmental cues. This dissertation mainly focuses on the cell-intrinsic molecular regulators of 
presynaptic development.  
 
1.1.1 Molecular regulators of presynaptic arborization. 
A variety of experimental systems have been used to study the molecular mechanism of 
presynaptic arborization. These include cultured hippocampal neurons, Drosophila dendritic 
arborization (da) neurons, cortical inhibitory neurons, neuromuscular junction (NMJ) and retinal 
ganglion cells (Takano et al. 2015; Wang, Sterne, and Ye 2014; Sanes and Lichtman 1999; Sanes 
and Masland 2015). Due to the scope and interest of this dissertation, I will focus on the 
presynaptic regulators identified in the first three experimental systems. 
 
Presynaptic regulators identified in vitro 
Cultured neurons from mouse or rat hippocampi are a widely used in vitro model for 
investigating the signaling pathways that regulate presynaptic growth. After plating, a 
hippocampal neuron in culture shows a symmetric appearance and lamella extension around the 
soma (defined as stage 1). After around 6 hours, the cell displays several minor neurites (defined 
as stage 2), one of which acquires axonal properties and extends rapidly to reach neighboring 
neurons (defined as stage 3). After reaching the destination, the axonal growth cone branches and 
forms synapses within these arbors (defined as stage 4 and 5) (Banker 2018; van Spronsen et al. 
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2013). Stage 2 and 3 have been extensively used to explore mechanisms underlying neuronal 
polarity, while stage 4 and 5 serves as a good in vitro model for studying presynaptic 
arborization (Banker 2018; van Spronsen et al. 2013). 
A series of presynaptic regulators have been identified, many of which belongs to tumor 
necrosis factor superfamily (TNFSF). For example, a proliferation-inducing ligand (APRIL), 
member 13 in TNFSF, promotes axonal branching and growth in cultured hippocampal 
pyramidal cells (Osorio et al. 2014). The effect of APRIL is through binding its receptor B-cell 
maturation antigen (BCMA) and activating PI3K/Akt/GSK-3β signaling in the developing 
neurons. Mutating either the receptor or the signaling component abolishes the axonal growth-
promoting effect of APRIL. Interestingly, no dendrite phenotype was observed, suggesting an 
axon-dedicated regulation of APRIL (Osorio et al. 2014). In addition, Fas ligand or CD95L, 
member 6 in TNFSF, exhibits similar function of stimulating axonal branching as APRIL 
(Zuliani et al. 2006). CD95L was best known as a trigger of apoptosis through binding to its 
receptor CD95 and activation of downstream effector caspases. Interestingly, Zuliani et al. found 
that CD95 is expressed in developing neurons without inducing apoptosis. The branching effect 
of CD95L is caspase-independent but via the adaptor -- Fas-associated protein with death 
domain (FADD) (Zuliani et al. 2006). 
By contrast, some TNFSF members play a negative role in regulating presynaptic 
arborization. For example, astrocytic glial cells secret tumor necrosis factor-α (TNFα), member 2 
in TNFSF, to inhibit axonal branching (Neumann et al. 2002).  In addition, TNFSF member 11, 
receptor activator of nuclear factor kappa-Β ligand (RANKL), was reported to inhibit both 
axonal and dendritic branching in cultured neurons (Gutierrez et al. 2013). Altogether, these 
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studies demonstrate TNFSF, especially their corresponding receptors expressed in developing 
neuron, play a critical role in presynaptic arborization.  
Other transmembrane proteins, such as Down syndrome cell adhesion molecule (Dscam), 
have been reported to be involved in presynaptic growth in cultured neurons (Zhang et al. 2015). 
Intriguingly, different molecular regulators may interact with each other to sculpt a final readout. 
For example, Dscam, which promotes axonal growth and branching, is negatively regulated by 
RANKL (Bando et al. 2018). Thus, it will be interesting to examine whether Dscam and RANKL 
antagonize each other to exert their function in regulating presynaptic arborization. A 
comprehensive view of the interaction network would be a necessary step for an in-depth 
understanding of presynaptic regulation at molecular levels.  
 
Presynaptic regulators identified in Drosophila 
Despite the valuable insights obtained from cultured cells, whether the functions of these 
regulators are conserved in vivo are largely unknown. Quantitative analyses of presynaptic 
arborization in vivo require sparse labeling and stereotyped morphology of the neurons of 
interest. In this regard, the Drosophila da neurons and mammalian cortical inhibitory neurons 
stand out.  
Drosophila Class IV dendritic arborization (C4da) neurons are nociceptors with their cell 
body and dendrites located in the larval body wall, while axons projecting to the ventral nerve 
cord (VNC), the Drosophila’s equivalent of vertebrate spinal cord (Figure 1.1A) (Grueber, Jan, 
and Jan 2002). The dendrites of C4da neurons tile the body wall and sense the noxious stimuli. 
The axons project to VNC and branch into stereotyped anterior, posterior, and contralateral 
projections at the axon terminals (Figure 1.1B). C4da axon terminals collectively form a ladder-
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like structure (Figure 1.1B) and convey the nociceptive signals to VNC to mediate escape 
behaviors (Hwang et al. 2007; Kim et al. 2012; Xiang et al. 2010).  Like other Drosophila 
neurons, C4da neurons are amenable to advanced genetic manipulation, such as mosaic analysis 
with a repressible cell marker (MARCM) (Lee and Luo 1999). Single-cell labeling techniques, 
such as MARCM, allows precise measurement of presynaptic arbors of signal neurons in vivo. 
The specific driver pickpocket (ppk)-Gal4 further facilitates genetic screens and reverse genetic 
tests (Grueber et al. 2003).  
A number of molecular regulators that control presynaptic arborization in C4da neurons 
have been identified. An important signaling axis is the PHR-DLK-Dscam-Abl signaling 
pathway. PHR refers to the Pam/Highwire/RPM-1 (PHR) family of E3 ubiquitin ligases. They 
ubiquitinate and trigger the degradation of the dual leucine zipper kinase (DLK). The PHR-DLK 
signaling cascade was first discovered in C. elegans motor neurons and then Drosophila NMJ 
(Collins et al. 2006; Nakata et al. 2005) . In Drosophila larvae, loss of function of the Drosophila 
homolog of PHR, hiw, causes the overexpression of Wnd, the Drosophila homolog of DLK, and 
presynaptic overgrowth in NMJ. Consistently, loss of Wnd rescues the NMJ phenotype caused 
by hiw mutation (Collins et al. 2006), demonstrating that Wnd functions downstream of Hiw.  
Our lab found that the function of Hiw-Wnd signaling pathway is conserved in 
Drosophila C4da neurons (Kim et al. 2013). In addition, we identified the critical role of Dscam 
in presynaptic arborization (Kim et al. 2013). Dscam is a single-pass membrane protein that is 
enriched in developing, but not mature, neurons (Schmucker et al. 2000; Li et al. 2020). 
Consistent with the expression profile, Dscam plays a role in regulating axonal growth in 
different neuronal types (Kim et al. 2013; Zhang et al. 2015; Bruce et al. 2017; Santos et al. 
2018; Chen et al. 2006). Dscam is positively regulated by Wnd and mediates Wnd’s growth-
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promoting effects on presynaptic arbors (Kim et al. 2013). In addition, the Ye lab identified the 
cytoplasmic tyrosine kinase Abl as a key downstream effector of Dscam. Abl physically interacts 
with Dscam to mediate its axon-promoting effects (Sterne, Kim, and Ye 2015a). The function of 
Abl in presynaptic extension is also conserved in other types of neurons (Wills, Bateman, et al. 
1999; Wills, Marr, et al. 1999; Wills et al. 2002; Hsouna, Kim, and VanBerkum 2003; Lee et al. 
2004; Forsthoefel et al. 2005). Altogether, these studies suggest a conserved role of the PHR-
DLK-Dscam-Abl signaling axis in instructing presynaptic arborization. Importantly, multiple 
Abl inhibitors have been approved by the US Food and Drug Administration (FDA) for treating 
chronic myeloid leukemia. Our lab found that treatment of these inhibitors is sufficiently to 
reverse the axonal overgrowth caused by Dscam overexpression in Drosophila larvae (Sterne, 
Kim, and Ye 2015a). This raises a novel possibility of treating neurological diseases with altered 
PHR-DLK-Dscam-Abl signaling axis.   
 
Presynaptic regulators identified in mammals 
Another in vivo experimental system for assaying presynaptic growth is the mammalian 
GABAergic neurons. G-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in 
mammalian brains. It is produced and released by GABAergic neurons to modulate-- usually 
inhibit-- the target cell activity (Lim et al. 2018; Tremblay, Lee, and Rudy 2016; Huang and Paul 
2019). Thus, GABAergic interneurons serve as the “brake” to maintain normal levels of brain 
excitation. Dysfunction of GABAergic neurons has been shown to cause a variety of 
neurological disorders (Ramamoorthi and Lin 2011; Ko, Choii, and Um 2015; Krueger-Burg, 
Papadopoulos, and Brose 2017). 
 
 
7 
 
GABAergic neurons are highly diverse in anatomical, electrophysiological and functional 
properties. Among the different types of GABAergic neurons, chandelier cells (ChCs),  the 
unique axo-axonic cells, have long captured the interest of neuroscientists because of its 
stereotyped morphology and innervation manner (DeFelipe 1999). Each ChC has hundreds of 
vertically oriented axon terminals that resemble a candelabrum, where its name is derived from 
(Figure 1.2A-B) (Blazquez-Llorca et al. 2015). Each axon terminal selectively innervates one or 
two pyramidal neurons (PyNs) at the axon initial segment (AIS), thus termed axo-axonic neuron 
(Figure 1.2C) (Jones 1975; Szentagothai 1975a). Unlike other types of GABAergic neurons that 
are highly variable in morphology, the stereotyped projection and innervation of ChC axon 
terminals make these neurons an advantageous model for investigating presynaptic arborization 
(Fazzari et al. 2010; Tai et al. 2014). Especially, with the advance of techniques, such as in utero 
electroporation (IUE) and ChC-specific mouse Cre-ER lines, mosaic labeling and manipulating 
of single ChCs become increasingly feasible (Tai et al. 2014; Fazzari et al. 2010; Taniguchi, Lu, 
and Huang 2013). It is exciting to see that a growing number of molecular regulators are being 
uncovered in controlling GABAergic neuron presynaptic arborization in mammalian brains. 
The NRG1-ERBB4 signaling cascade regulates ChC presynaptic growth (Fazzari et al. 
2010). Neuregulin1 (Nrg1) is a cell adhesion molecule with ERBB4, a receptor tyrosine kinase, 
as its receptor. NRG1 and ErbB4 are known to be schizophrenia-susceptibility genes and have 
been considered to regulate neuronal wiring in excitatory cells. Fazzari and the colleagues found 
that ERBB4 is mainly localized in GABAergic neurons and localized at the presynaptic site. Via 
combining IUE and embryonic virus injection, the authors carried out both gain- and loss-of-
function experiments demonstrating that NRG1-ErbB4 signaling cell-autonomously promotes 
ChC axon terminal growth and synapse formation (Fazzari et al. 2010). This study identified the 
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first molecular regulators of ChC presynaptic growth and corroborated the previous finding of 
impaired ChC axon terminal growth in schizophrenia patients (Lewis 2011; Konopaske et al. 
2006). Deleting ERBB4 in ChCs causes schizophrenia-like phenotypes in mice, demonstrating 
the importance of NRG1-ERBB4-controlled ChC development in neurological disorders (Del 
Pino et al. 2013; Yang et al. 2019). In addition to the NRG1-ErbB4 signaling, Nkx2.1, DOCK7, 
Fgf13 and L1CAM have also been found to regulate the ChC presynaptic formation (Fazzari et 
al. 2010; Tai et al. 2014; Favuzzi et al. 2019; Tai et al. 2019). Importantly, besides arbor 
extension, ChCs have also been used to identify factors that regulates presynaptic orientation and 
synaptic formation, suggesting the broad applications of this experimental model (Fazzari et al. 
2010; Tai et al. 2014; Favuzzi et al. 2019; Tai et al. 2019).  
 
1.1.2 Molecular regulators of synapse formation. 
The human brain contains around 86 billion neurons. Each makes more than one 
thousand synaptic connections with other neurons on average (Herculano-Houzel 2009). 
Altogether, these trillions of synapses sculpt how we respond to internal and external stimuli. 
Elucidating how a synapse is organized has long been an interest in the neuroscience field. Based 
on the effect of released neurotransmitter on postsynaptic neuronal firing, synapses are divided 
into excitatory or inhibitory. In mammalian brains, glutamatergic synapses are the major 
excitatory synapses, while GABAergic the major inhibitory synapses. Because of the dissertation 
interest and space limitation, I will mainly focus on molecular organizers of GABAergic 
synapses at the presynaptic site.  
Neurexins are presynaptic cell surface molecules crucial for synapse formation (Missler, 
Sudhof, and Biederer 2012). They are localized in presynaptic terminals of inhibitory synapses 
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and interact with particular postsynaptic transmembrane proteins. For example, neurexins bind to 
neuroligin-2, the first discovered inhibitory synapse-specific transsynaptic organizer, via the 
extracellular acetylcholinesterase domain (Poulopoulos et al. 2009; Krueger et al. 2012). This 
physical interaction mediates the specific postsynaptic localization of Neuroligin-2, and is 
required for its function in clustering postsynaptic GABA receptors and scaffolding proteins 
(Krueger-Burg, Papadopoulos, and Brose 2017). In addition, neurexins have been shown to 
interact with other postsynaptic proteins, such as dystroglycan and neurexophilin 1(Waite, 
Brown, and Blake 2012; Reissner et al. 2014). Interestingly, these pre/post-synaptic interactions 
are modulated to form a complex regulatory network for synapse development. For example, 
calsyntenin-3 is a member of the cadherin superfamily of cell adhesion molecules. Proteolytic 
cleavage of calsyntenin-3 releases the ectodomain that prevents neurexin- neuroligin -2 
interaction, thus causing the inhibitory effects on synaptogenesis (Pettem et al. 2013; Um et al. 
2014). 
IgSF9 and IgSF9b are two members of the immunoglobulin superfamily member 9 
(IgSF9) transmembrane protein family. These two homophilic cell adhesion proteins are thought 
to be localized at both pre and post-synaptic sites (Ko, Choii, and Um 2015; Krueger-Burg, 
Papadopoulos, and Brose 2017). IgSF9 was originally reported to promote excitatory synapse 
development based on RNA interference (Shi et al. 2004). However, recent studies using IgSF9-
deficient mice refuted this hypothesis in that hippocampal dendrite growth or branching remains 
intact in this mutant mice (Mishra et al. 2008). By contrast, IgSF9-deficient mice show reduced 
inhibitory synapse density and synaptic transmission, suggesting a critical role in inhibitory 
synaptogenesis.  Interestingly, IgSF9 exerts such effects independent of its cytoplasmic domain 
as the knock-in mice expressing IgSF9 without intracellular domain causes no inhibitory defects 
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(Mishra et al. 2014). By contrast, IgSF9b is thought to specifically regulate inhibitory synapse 
formation between GABAergic interneurons via its binding to neuroligin-2 at the intracellular 
domain (Woo et al. 2013). Additionally, several other transmembrane proteins have been shown 
to function presynaptically. Protein tyrosine phosphatase receptor, PTPd, binds postsynaptic slit- 
and trk-like (Slitrk) family member 3 (Slitrk3) to promote inhibitory synapse development and 
function in hippocampal CA1 neurons (Takahashi et al. 2012).  Deletion of ERBB4, the receptor 
of neuregulin 1, cell autonomously impairs the presynaptic bouton growth in ChCs and synaptic 
transmission in inhibitory neurons (Fazzari et al. 2010).  
Besides the transmembrane proteins, a variety of cytoplasmic synapse regulators have 
been identified, mainly in the GABAergic Dorsal D-type motor neurons (hereafter termed DD 
neurons) of C. elegans. During the maturation of C. elegans larvae, DD neurons forms new 
synapses with dorsal body wall muscles that are critical for worm locomotion. Interestingly, the 
synapse formation is not involved with overt changes in presynaptic arborization, thus providing 
an ideal model to study the molecular mechanisms underlying GABAergic synapse development 
(Kurup and Jin 2016). 
Transcript levels of DLK, a regulator of presynaptic arborization as described in previous 
sections, is boosted to facilitate synapse formation during the maturation of DD neurons (Kurup 
et al. 2015; Grun et al. 2014). The effect of DLK is mediated by increasing the dynamic 
microtubule amount at the presynaptic sites by acting on microtubule catastrophe factors, such as 
Kinesin-13 and Spastin (Kurup et al. 2015; Nakata et al. 2005; Roll-Mecak and McNally 2010). 
The increased dynamic microtubule facilitates synaptic vesicle transport, which is mediated by 
UNC-116, the C. elegans homolog of vertebrate motor protein kinesin-1. Gain of function of 
UNC-116 is sufficient to rescue the impaired synapse formation in DD neurons caused by the 
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mutations including DLK (Kurup et al. 2015). In addition, cyclin-dependent kinase-5 (CDK-5) 
has been shown to promote new synapse formation in DD neurons of mature C. elegans by 
elevating the activity of UNC-104/Kinesin3 (Park et al. 2011). After synapse formation, TTBK-
3, a member of the Casein-kinase (CK1) superfamily in C. elegans, inhibits the stabilization of 
these nascent synapses on the dorsal neurite (Kurup et al. 2017).   
However, compared with the long list of postsynaptic organizers, the presynaptic 
organizers are relatively less understood. One technical challenge is that presynaptic active zones 
are more insoluble by detergents than postsynaptic density, and are thus difficult to purify 
(Sudhof 2012). Recently, spatially restricted proximity labeling has enabled mass spectrometry-
based quantitative proteomics in various sub-neuronal structures, such as synaptic cleft, post-
synaptic density, axon initial segment and neuronal surface (Loh et al. 2016; Uezu et al. 2016; 
Hamdan et al. 2019; Li et al. 2020). Such technique, when applied in presynaptic active zones, is 
expected to significantly advance the field. 
 
1.2 Isoform diversity contributes to the signaling complexity of presynaptic development 
Human has ~20,000 protein coding genes, but ~200,000 protein products. This is caused 
by alternative splicing. Alternative splicing is ubiquitous and evolutionarily conserved regulatory 
mechanism that enables eukaryotic cells to generate vast protein diversity from limited gene 
number. Through alternative splicing, a single pre-mature RNA can generate different mRNAs 
with distinct coding regions by mutually exclusive exons, exon skipping, alternative splicing site 
or intron retention. This distinct combination of coding sequences generates different protein 
isoforms with diverse biochemical and physiological properties. This proteome complexity 
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exponentially expands the signaling complexity in cells, especially when we consider it at the 
subcellular levels.  
Alternative splicing may change the subcellular localization of targeted isoforms by 
introducing specific coding sequences that contain signals for subcellular localization, post-
translational modification or protein interaction (Kelemen et al. 2013). Protein isoforms may 
exert distinct functions in different subcellular compartments. For example, determined by 
inclusion or exclusion of an alternative exon, the LPIN1 gene generates a nuclear isoform that 
acts as a transcription factor and a cytoplasmic variant with phosphatidate phosphatase activity 
(Han and Carman 2010; Zhang et al. 2012). Similar scenario is observed in other genes, such as 
that of Rbfox1, with a nuclear variant (excluding exon 19) that regulates RNA splicing and a 
cytoplasmic variant (including exon 19) that stabilizes mRNAs (Lee et al. 2016). However, a 
caution needs to be taken in that most of these studies are carried out in vitro with cDNA 
constructs that lack endogenous cis and trans-regulation. Whether these findings apply in vivo 
awaits further studies (Kelemen et al. 2013). 
In Drosophila, alternative splicing of Dscam, a molecular regulator of presynaptic growth 
and neurite self-avoidance, produces two isoforms with mutually exclusive exons that encode 
distinct transmembrane and juxtamembrane region, called Dscam[TM1] and Dscam[TM2], 
respectively (Schmucker et al. 2000). Previous studies suggest that Dscam[TM1] and 
Dscam[TM2] may differentially regulate presynaptic growth in Drosophila. For example, 
overexpression of Dscam[TM2] in Drosophila mushroom body, a CNS neural ensemble 
involved in Drosophila learning and memory, cause its ubiquitous presence in both axons and 
dendrites. By contrast, Dscam[TM1] is largely restrained in somatodendrites (Zhan et al. 2004; 
Wang et al. 2004b). These data suggest that Dscam[TM2] and [TM1] may have distinct 
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subcellular localization. Consistently, Dscam[TM2] better rescues the branching defects in 
Drosophila mushroom body caused by Dscam mutant than Dscam[TM1] (Zhan et al. 2004). 
However, in Drosophila C4da neurons, which are nociceptors, overexpression of Dscam[TM1] 
results in a expression profile reminiscent that of [TM2] (Soba et al. 2007). And both 
Dscam[TM1] and [TM2] have been reported to cause the same defects in axonal segregation 
when overexpressed in mushroom body (Zhan et al. 2004). Are these discrepancies caused by 
neuronal specificity or artificial effects of overexpression? Answering this question requires the 
interrogation the endogenous localization and function of Dscam isoforms at the endogenous and 
subcellular levels in vivo, which is not feasible with current techniques. 
In the first part of my dissertation, I developed a novel genetic method, termed isoTarget, 
which enables the investigation of isoform-specific function, endogenous localization and 
signaling at cell type-specific levels in vivo. By applying isoTarget in Dscam[TM1] and [TM2], I 
found that presynaptic growth is specifically regulated by Dscam[TM2] by its unique presence 
there. In addition, I uncovered a Wnd-Dscam[TM2]-Dock signaling cascade that specifically 
occurs at the presynaptic site. Interestingly, I found that this compartmentalized signaling is not 
caused by the unique biochemical properties of Dscam[TM2] but by the presynaptic enrichment 
of Wnd and Dock. Thus, isoTarget is expected to be a useful tool to dissect the signaling 
complexity caused by isoform diversity at the subcellular levels, including that of presynaptic 
arbors. 
 
1.3 Dysregulated expression levels of presynaptic regulators in neurodevelopmental 
disorders. 
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GABAergic neurons are the major inhibitory neurons in the mammalian brain (Lim et al. 
2018; Tremblay, Lee, and Rudy 2016). Dysregulated GABAergic system causes a variety of 
neurodevelopmental disorders (Ramamoorthi and Lin 2011). For example, impaired forebrain 
GABAergic neurons cause autism-like symptoms, such as repetitive behavior (Chao et al. 2010). 
While GABAergic hyper-functioning causes Down syndrome symptoms, such as impaired 
spatial leaning (Fernandez et al. 2007; Braudeau, Delatour, et al. 2011; Colas et al. 2013a; 
Martinez-Cue et al. 2013). To date, a growing number of molecular regulators have been 
identified to control presynaptic development in GABAergic neurons. Intriguingly, copy number 
variations of these genes are commonly found in a variety of neurological diseases (Ko, Choii, 
and Um 2015), suggesting that dysregulated expression of these genes may cause the disease 
pathology. However, whether or not this is true remains largely unknown. 
Down syndrome is caused by an extra copy of chromosome 21 or a segment of it, which 
results in the triplication of up to about 200 genes in human patients. It is the most common 
aneuploid disorder that causes intellectual disability (Gardiner et al. 2010).  The most widely 
used mouse model of Down syndrome is Ts65Dn, which contains a trisomic chromosomal 
region that is homologous to about half of human chromosome 21 (Reeves et al. 1995). Ts65Dn 
mice exhibit a variety of behavioral deficits reminiscent that of human patients (Reeves et al. 
1995). A milestone in DS pathogenesis is the discovery that Ts65Dn behavioral deficits can be 
blocked by GABA receptor antagonist (Fernandez et al. 2007; Braudeau, Delatour, et al. 2011; 
Colas et al. 2013a; Martinez-Cue et al. 2013), suggesting that activated GABAergic signaling is 
the pathological driver. Uncovering the molecular mechanisms of GABAergic hyperfunctioning 
is the key for pharmaceutical treatment of Down syndrome.  
 
 
15 
 
One gene that is triplicated in DS and involved in neurodevelopment is Dyrk1A, the 
human orthologue of the Drosophila minibrain gene. Dyrk1A encodes a serine-threonine kinase 
that is highly expressed in neuroblast during embryonic neurogenesis (Okui et al. 1999) 
(Hammerle, Elizalde, and Tejedor 2008; Hammerle et al. 2002). Loss of Dyrk1A has been shown 
to cause microcephaly in humans and reduced brain size in mice (Moller et al. 2008; Fotaki et al. 
2002). Transgenic overexpression of Dyrk1A causes impaired motor behavior, spatial learning 
and cognitive function, reminiscent of the symptoms in DS patients (Altafaj et al. 2001; Martinez 
de Lagran et al. 2004). Indeed, Normalizing Dyrk1A dosage in Ts65Dn DS mouse model has 
been shown to rescue the GABAergic synapse overgrowth and cognitive defects (Garcia-Cerro et 
al. 2014) , suggesting a direct contribution of Dyrk1A triplication to DS pathogenesis. 
Interestingly, green tea flavonol epigallocatechin‐gallate (EGCG ), an inhibitor of Dyrk1A, 
rescues the cognitive deficits in both Ts65Dn mice and DS patients (De la Torre et al. 2014), 
raising Dyrk1A as a promising therapeutic target for cognitive treatment in DS. Besides Dyrk1A, 
the extra copy of amyloid precursor protein gene, App, causes the degeneration of basal forebrain 
cholinergic neurons in Ts65Dn and Ts1Cje mouse models of DS (Salehi et al. 2006). Triplication 
of Kcnj6, a gene that encodes the GABAB receptor-coupled G protein-coupled inward rectifying 
potassium channel subunit 2 (GIRK2), has been shown to promote the infantile spasms induced 
by GABAB receptor agonists in Ts65Dn mice(Joshi et al. 2016). 
Chakrabarti and the colleagues found that triplication of Olig1 and Olig2 cause the 
overproliferation of parvalbumin-  and somatostatin-expressing inhibitory neurons in Ts65Dn 
neocortex and hippocampus (Chakrabarti et al. 2010). These findings provide the first celluar 
basis for GABAergic overinhibition in the DS mouse model (Chakrabarti et al. 2010; 
Contestabile, Magara, and Cancedda 2017; Haydar and Reeves 2012).  Meanwhile, several lines 
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of evidence suggest that heterogeneous etiology may exist. For example, the sizes of synaptic 
boutons and inhibitory synapses are enlarged in the neocortex of Ts65Dn mice, suggesting a 
post-mitotic GABAergic synaptic dysfunctions in the neocortex (Belichenko et al. 2009; Kurt et 
al. 2000; Belichenko et al. 2004). However, which subtype of GABAergic neurons are affected 
and the triplication of which gene causes the pathogenic defects remains unknown.  
Down syndrome cell adhesion molecule (Dscam) is an evolutionarily conserved type I 
transmembrane protein (Yamakawa et al. 1998). In human, Dscam gene is localized in the Down 
syndrome critical region on chromosome 21 (hCh21) (Yamakawa et al. 1998). Altered Dscam 
expression levels have been reported in multiple brain disorders, including Down syndrome, 
autism spectrum disorders, intractable epilepsy and bipolar disorder (Saito et al. 2000; O'Roak et 
al. 2014; Krumm et al. 2015; Turner et al. 2016; Shen et al. 2011; Amano et al. 2008), suggesting 
a potential pathogenic role. Indeed, we show that Dscam promote neuronal growth in a dosage-
dependent manner (Kim et al. 2013; Cvetkovska et al. 2013; Lowe, Hodge, and Usowicz 2018). 
In addition, Dscam is enriched in developing neurons, when dendrite/axon are differentiating (Li 
et al. 2020; Mayer et al. 2018; Mi et al. 2018). These findings suggest that dysregulated Dscam 
levels might contribute to the post-mitotic GABAergic defects in Down syndrome.  
The second part of my dissertation focus on the role of Dscam gene triplication in 
GABAergic dysfunctions in Down syndrome. By using Ts65Dn as the mouse model of Down 
syndrome, we found that the presynaptic arborization and synaptogenesis are boosted in ChCs 
and basket cells, two major types of GABAergic neurons. Genetic normalization of Dscam 
expression rescues the excessive GABAergic innervation and synaptic transmission. Conversely, 
Loss of Dscam impairs the presynaptic development and functioning in inhibitory neurons. 
These findings identify the genetic basis of post-mitotic GABAergic defects in Down syndrome 
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and implicate dysregulated Dscam levels as a common pathogenic driver in related neurological 
disorders. 
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Figure 1.1. Scheme of Drosophila larval C4da neurons. 
(A) Schematic image of Drosophila larval C4da neurons. Each hemisegment is tiled by the 
dendrites of three C4 da neurons (light green). For each C4da neuron (red), the dendrites and cell 
body are on the body wall while the axons are sent to the VNC of larval brain. 
(B) Magnified image of C4da neuron axons. The presynaptic arbor of a single C4da neuron 
shows anterior (A), posterior (P) and contralateral (C) projects (Red). The axons of C4da neuron 
together form a ladder- like structure (Green). 
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Figure 1.2. Representative images of single ChCs and ChC-PyN synases. 
(A) A single ChC labeled by tdTomato through Nkx2.1CreERT2.  The soma of this ChC is located 
at the border of layers I and II in neocortex.   
(B) 3-D tracing of a single ChC. The soma of this ChC is located at the L1-L2 border in 
somatosensory cortex.  The dendrites are marked in red, and the axons—including terminals—are 
labeled in various colors, each representing a separate arbor.  
(C) The cartridges of ChC axon terminals. Red: boutons on ChC axon terminals labeled by 
tdTomato; Green: pyramidal cell AIS labeled by anti-phospho-IκBα.  White and pink arrows point 
to the boutons on two different cartridges.  
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Chapter 2 
isoTarget: a Genetic Method for Analyzing the Functional Diversity of 
 Splicing Isoforms in vivo 
 
This chapter is modified after a research article that is under revision for publication with authors 
listed as Hao Liu, Sarah Pizzano, Ruonan Li, Wenquan Zhao, Macy W. Veling, Yujia Hu, Limin 
Yang, and Bing Ye. 
 
2.1 Abstract 
Protein isoforms generated by alternative splicing contribute to proteome diversity. Due 
to the lack of effective techniques, isoform-specific functions, expression, localization, and 
signaling mechanisms of endogenous proteins in vivo are unknown for most genes. Here we 
report a genetic method, termed isoTarget, for blocking the expression of a targeted isoform 
without affecting the other isoforms and for conditional tagging the targeted isoform for multi-
level analyses in select cells. Applying isoTarget to two mutually exclusive isoforms of 
Drosophila Dscam, Dscam[TM1] and [TM2], we found that endogenous Dscam[TM1] is 
localized in dendrites while Dscam[TM2] is in both dendrites and axons. We demonstrate that 
the difference in subcellular localization between Dscam[TM1] and [TM2], rather than any 
difference in biochemical properties, leads to the two isoforms’ differential contributions to 
dendrite and axon development. Moreover, with isoTarget, we discovered that the subcellular 
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enrichment of functional partners results in a DLK/Wallenda-Dscam[TM2]-Dock signaling 
cascade specifically in axons. isoTarget is an effective technique for studying how alternative 
splicing enhances proteome complexity.  
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2.2 Introduction 
Alternative splicing is a fundamental biological process that expands proteome diversity 
in eukaryotes. Genome-wide transcriptome analyses have shown that 90%-95% of human genes 
encode two or more isoforms (Baralle and Giudice 2017). The percentage of multi-exonic genes 
that undergo alternative splicing is estimated to be 63% in mouse, 45% in Drosophila, and 25% 
in C. elegans (Lee and Rio 2015). Alternative splicing is regulated by the coordination of RNA-
binding proteins, RNA polymerase II, and epigenetic modifications of DNA (Baralle and 
Giudice 2017). Perturbations of RNA splicing cause neurodevelopmental, cardiovascular, and 
other diseases (Baralle and Giudice 2017; Scotti and Swanson 2016). Despite these important 
findings, how distinct protein isoforms resulted from alternative splicing differ in their functions 
and regulations are poorly understood. In fact, the cellular functions, endogenous expression and 
localization, and signaling cascades of individual splicing isoforms are only known for a very 
small number of genes (Baralle and Giudice 2017). 
        Protein isoforms encoded by alternative exons often differ in their structures and 
biochemical properties, which lead to distinct functions of the isoforms (Kelemen et al. 2013). In 
addition, different types of cells may express different splicing variants (Baralle and Giudice 
2017), which further diversifies the biological functions of different isoforms. Intriguingly, 
different protein isoforms of some genes are localized to distinct subcellular compartments 
within the same cell (Kelemen et al. 2013; Baralle and Giudice 2017; Lee et al. 2016; Yap and 
Makeyev 2016; Lerch et al. 2012). Compared to our understanding of how biochemical and 
expressional differences contribute to distinct functions of splicing isoforms, much less is known 
about whether and how isoform-specific subcellular localization contributes to distinct cellular 
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functions. This is a challenging problem because solving it requires manipulating a specific 
isoform at its endogenous locus—without affecting other isoforms—in a cell-specific fashion. 
         Transgene-mediated overexpression of splicing variants of interest is widely used for 
studying isoform-specific functions and subcellular localization in specific cells. However, it is 
well documented that overexpressed proteins often do not mimic the endogenous proteins in 
their spatiotemporal expression, localization, and functions (Kelemen et al. 2013; Baralle and 
Giudice 2017; Prelich 2012; Moriya 2015).  
           Here, we report a genetic method, termed isoTarget, for studying isoform-specific 
function, localization, and signaling of endogenous splicing isoforms of interest. This method 
allows to knock out a select isoform for functional studies and to tag conditionally the 
endogenous proteins for multi-disciplinary analyses in specific cells without affecting other 
isoforms. To achieve these, we created a translational stop sequence, used it to generate a 
cleavable cassette that contains an epitope tag for conditional tagging, and inserted the cassette 
into the exon encoding the isoform of interest. As a proof-of-concept, we applied isoTarget to 
study two mutually exclusive isoforms of Drosophila Down syndrome cell adhesion molecule 
(Dscam), Dscam[TM1] and [TM2] (Schmucker et al. 2000; Wang et al. 2004a; Zhan et al. 2004). 
We report isoform-specific functions for Dscam[TM1] and [TM2] resulting from the distinct 
endogenous subcellular localization patterns of these two isoforms. We further describe a 
compartment-specific signaling pathway in the axon terminals, which involves Dscam[TM2], but 
not [TM1], as a result of the differential localization of the two isoforms and their functional 
partners. These findings illustrate the versatility of isoTarget in isoform studies and its 
effectiveness in uncovering mechanisms governing the expansion of proteome diversity by 
alternative splicing in vivo. In addition, they establish the causality between the subcellular 
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localization and cellular function of Dscam splicing isoforms, demonstrating the critical role of 
subcellular localization in expanding the functional diversity of splicing isoforms.  
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2.3 Results 
The design of isoTarget 
The transcriptional stop cassettes commonly used for conditional knockouts or knockins 
(Lakso et al. 1992) do not specifically disrupt the expression a select splicing isoform and are 
hence not applicable for isoform-specific studies. This is because RNA splicing occurs after 
transcription and, as a consequence, transcriptional stop cassettes disrupts the expression of all 
isoforms downstream of the targeted isoform (Figure 2.1A). To meet this challenge, we created a 
translational stop (tlstop) sequence by introducing multiple stop codons (TAA, TAG or TGA) 
into the DNA sequence encoding a non-catalytic region of β-Galactosidase (β-Gal) (Figures 
2.1A, 2.2A). If the tlstop is present in an isoform-specific exon, it would lead to isoform-specific 
truncation during mRNA translation (Figure 2.1A). 
 To achieve cell-type-specific labeling of targeted isoforms, the tlstop sequence is flanked 
by two R recombinase recognition sites (RSRT) followed by an epitope tag (Chen et al. 2014; 
Nern et al. 2011). When R recombinase is expressed to remove tlstop, the epitope tag is inserted 
in-frame into the targeted isoform, allowing the detection and biochemical analyses of 
endogenous proteins in cells of interest (Figure 2.1B). We refer to the RSRT-tlstop-RSRT as 
“iso-KO cassette” (for “isoTarget knockout cassette”), as its insertion into an isoform-specific 
exon is expected to create a loss-of-function mutant of this particular isoform. In Drosophila, the 
iso-KO alleles can be used in combination with the mosaic analysis with a repressible cell 
marker (MARCM) (Lee and Luo 1999) to study isoform-specific function in targeted single 
neurons (Figure 2.1B). We refer to the RSRT-epitope resulted from the excision of the tlstop 
sequence as “iso-Tagging cassette”. As we show below, the iso-Tagging approach allows the 
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investigation of upstream and downstream signaling mechanisms that involve targeted isoform at 
the organismal, cell-type-specific, or subcellular levels (Figure 2.1B). 
 
The validation of isoTarget and mitigation of off-target effects of translational-stop 
cassettes 
To fulfill the designed applications, the isoTarget technique should meet the following 
requirements. First, the iso-KO cassette must abolish the function of the targeted isoform. 
Second, the iso-KO or iso-Tagging cassette in one isoform should not impair the expression of 
other isoforms. Third, iso-Tagging—resulted from the excision of the iso-KO cassette—should 
restore the isoform functions that are disrupted by the iso-KO cassette. We determined whether 
isoTarget met these prerequisites by testing on the Drosophila Dscam gene. 
In Drosophila, exon 17.1 and 17.2 of Dscam gene encode two different 
transmembrane/juxtamembrane domains (Schmucker et al. 2000). Alternative splicing of these 
two mutually exclusive exons produces two isoforms called Dscam[TM1] and Dscam[TM2] 
(Figure 2.2B). We inserted the iso-KO cassette into the juxtamembrane domain in exon 17.1 
(TM1) and 17.2 (TM2) (Figures 2.2B-C). In homozygous Dscam[TM2] iso-KO (Dscam[TM2]iso-
KO) larvae, the axon terminal growth was dramatically impaired in the class IV dendritic 
arborization (C4da) neurons (Figures 2.3A-B, and H), a widely used model for studying dendrite 
and axon development (Grueber and Jan 2004; Grueber et al. 2007; Jan and Jan 2010; Ye et al. 
2007). This is consistent with previous reports that Dscam is required for axon terminal growth 
in C4da neurons (Kim et al. 2013), and suggests that iso-KO cassette abolishes Dscam[TM2] 
functions. The impaired growth of axon terminals was completely rescued in homozygous global 
Dscam[TM2] iso-Tagging (Dscam[TM2]iso-Tagging) larvae resulted from the excision of the iso-
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KO cassette (Figures 2.2C, 2.4A-B), suggesting that tagging endogenous Dscam[TM2] with the 
epitope tag (V5) does not disrupt the function of the isoform.  
Next, we determined whether isoTarget of one isoform affected the expression of another 
isoform by using quantitative real-time PCR and immunohistochemistry on isoTarget samples. 
Dscam[TM1] mRNA levels were not affected in the brains of homozygous Dscam[TM2]iso-KO or 
Dscam[TM2]iso-Tagging 3rd-instar larvae (Figure 2.4C). Unexpectedly, the [TM1] iso-KO cassette 
abolished Dscam[TM2] mRNA and protein expression, creating a Dscam[TM1/2]iso-KO mutant 
(Figures 2.5A-C). By contrast, the expression of Dscam[TM2] mRNA was not affected by 
Dscam[TM1] iso-Tagging cassette (Figure 2.5A). These results suggest that inserting a long 
piece of DNA in TM1-encoding exon disrupts the splicing of TM2-encoding exon of Dscam pre-
mRNA (Figure 2.5F), possibly by overly extending the distance between exon 16 and the TM2-
encoding exon (Anastassiou, Liu, and Varadan 2006). To test this possibility, we reduced the 
size of the iso-KO cassette from 561 bp to 285 bp by cutting a 276 bp-fragment from the tlstop 
sequence. Strikingly, insertion of the short iso-KO cassette in [TM1] did not impair 
Dscam[TM2] expression, including both mRNA and protein expression (Figures 2.5A and 2.5D-
E). Through these studies, we discovered that the impact of an isoTarget cassette on off-target 
isoforms can be mitigated by reducing the cassette length and found a new translational stop 
sequence for achieving this. 
Taken together, these results validate the use of isoTarget for studying endogenous 
Dscam[TM1] and [TM2] isoforms. 
 
Uncovering the functions of Dscam isoforms in axon terminals with isoTarget 
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We previously demonstrated that in larval PNS neurons Dscam instructs the presynaptic 
terminal growth, which is a function that is distinct from Dscam’s role in neurite self-avoidance 
(Kim et al. 2013). However, whether both Dscam[TM1] and [TM2] contribute to this process is 
unknown. With iso-KO larvae, we found that knocking out the [TM2] isoform impaired axon 
terminal growth in larval C4da neurons (Figures 2.3A-B and H). By contrast, the axonal 
development remained intact in Dscam[TM1]iso-KO  larvae (Figures 2.3C and H). Next, we 
combined isoTarget with the MARCM technique to determine whether the Dscam isoforms 
functioned cell-autonomously to regulate C4da axon terminal growth. Single C4da neurons that 
were homozygous for Dscam[TM1]iso-KO had normal axon terminal growth (Figures 2.3D-E and 
I). By contrast, loss of Dscam[TM2] in C4da neurons significantly impaired axon terminal 
growth to the same levels as loss of Dscam (Figures 2.3F-G and I). 
 Similar to C4da neurons, while C3da neurons in homozygous Dscam[TM1]iso-KO larvae 
showed normal growth of axon terminals, those in homozygous Dscam[TM2]iso-KO displayed 
dramatically reduced axon terminals growth, as evident in the gaps in longitudinal axon tracts 
(Figures 2.3J-L). The disruption in longitudinal axon tracts was also observed in 
Dscam[TM1/2]KO larvae (Figure 2.3M). 
 These results suggest that Dscam[TM2], but not Dscam[TM1], regulates the growth of 
axon terminals. 
 
Uncovering the functions of Dscam isoforms in dendrites with isoTarget 
Dscam has been shown to mediate dendritic self-avoidance without affecting dendritic 
growth in the PNS neurons of Drosophila larvae (Matthews et al. 2007; Soba et al. 2007; Hughes 
et al. 2007). Again, it is unknown whether both Dscam[TM1] and [TM2] isoforms are 
 
 
29 
 
responsible for this process. We applied isoTarget to answer this question. As expected from 
previous studies, homozygous Dscam[TM1/2]iso-KO mutant larvae, which lack both [TM1] and 
[TM2] functions, exhibited increased dendritic crossing in both C3da mechanosensors (Figures 
2.6A-B and E) and C4da nociceptors (Figures 2.7A-B and E), indicating defective avoidance 
among dendrites of the same neuron. Different from what we observed in axons, neither 
Dscam[TM1]iso-KO nor Dscam[TM2]iso-KO caused any defect in dendritic self-avoidance in these 
neurons (Figures 2.6C-D and E, 2.7C-D and E). 
 We further combined MARCM with isoTarget to study cell-autonomous functions of 
targeted isoforms in single cells. As previously shown (Matthews et al. 2007; Soba et al. 2007; 
Hughes et al. 2007), single C4da neurons that were homozygous of Dscam18, which abolishes 
both [TM1] and [TM2] isoforms, showed significant self-avoidance defect (Figures 2.6G and J). 
By contrast, loss of either Dscam[TM1] or [TM2] in single C4da neurons did not cause any 
defect in dendritic self-avoidance (Figures 2.6H-I and J). 
These results suggest that Dscam[TM1] and [TM2] function redundantly in dendritic 
self-avoidance. Thus, these two isoforms function differently in dendrite and axon development. 
 
Using isoTarget to identify the subcellular localizations of endogenous protein isoforms  
Previous studies have shown that in CNS neurons transgenic Dscam[TM1] is restrained 
in somatodendritic compartments while [TM2] is in both dendrites and axons (Wang et al. 
2004a; Yang, Bai, and Lee 2008; Zhan et al. 2004). However, transgenic Dscam[TM1] and 
[TM2] were both found to be ubiquitously present in PNS neurons (Soba et al. 2007) (Figures 6B 
and D and data not shown). Does this discrepancy indicate that the subcellular localization of 
Dscam isoforms varies in different neuronal types? To answer this question, we applied iso-
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Tagging to examine the subcellular localizations of endogenous Dscam isoforms in both PNS 
and CNS neurons. We found that in PNS neurons both endogenous Dscam[TM1] and [TM2] 
were localized in the dendrites (Figures 2.8A-C). Interestingly, different from what we observed 
with Dscam transgenes, only endogenous Dscam[TM2] was localized in the presynaptic 
terminals of PNS neurons (Figures 2.8D and E). Similar isoform-specific localization patterns 
were observed in CNS neurons. By iso-Tagging in mushroom body (MB) neurons in the 3rd-
instar larva, we observed both endogenous Dscam[TM1] and [TM2] in MB calyx (Figures 2.8F-
H), which is a cluster of dendritic branches, but only [TM2] in the core fibers of axonal 
peduncles (Figures 2.8I-K). The finding that only [TM2] is localized in axons was further 
supported by the observation of Dscam proteins in axonal shafts that connect the PNS and CNS. 
In iso-Tagging larvae, despite a substantial amount of Dscam[TM1] signals in the neuropil 
region of the ventral nerve cord (VNC), no [TM1] signal was observed in axonal shafts (Figures 
2.9A-B). By contrast, Dscam[TM2] puncta were abundant in axonal shafts in global 
Dscam[TM2]iso-Tagging larvae (Figure 2.9C). Taken together, we found that in PNS and CNS, both 
endogenous Dscam[TM1] and [TM2] isoforms are present in dendrites, while only [TM2] is in 
axons. 
Notably, endogenous Dscam expression seemed to be enriched in developing neurons, 
but not in mature ones. While both endogenous Dscam[TM1] and [TM2] were observed in PNS 
neurons at the early 2nd-instar stage, no signal was detectable in the 3rd instar stage (data not 
shown). In larval MB, endogenous Dscam[TM2] was detected only in the core fiber, which is the 
axonal projections of nascent developing neurons. These observations are consistent with 
previous immunostaining results with an anti-Dscam antibody (Zhan et al. 2004). The 
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discrepancies of spatiotemporal expression pattern between transgenes and endogenous Dscam 
isoforms underscore the importance of studying protein isoforms at the physiological level. 
 
Dendrite-specific localization restrains endogenous Dscam[TM1] from functioning in axons 
The studies above show that endogenous Dscam[TM1] is required for dendritic, but not 
axonal, development. Although this could be a result of the compartmentalized localization of 
Dscam[TM1] in dendrites, trans-compartmental communication has been shown for many 
membrane proteins . It is thus essential to determine whether or not the dendrite-specific 
localization of Dscam[TM1], instead of its biochemical properties, restrains it from functioning 
in axons. This important issue has not been addressed, despite previous insightful studies on the 
differences between Dscam[TM1] and [TM2]. 
 We determined whether forced localization of Dscam[TM1] in axon terminals was 
sufficient to rescue the axon phenotype caused by Dscam[TM2]iso-KO. Overexpression of a 
Dscam[TM1] transgene in C4da neurons led to a modest level of Dscam[TM1] in axon terminals 
and significantly mitigated axonal growth defects caused by Dscam[TM2]iso-KO (Figures 2.10A-
B, and F). As expected, two different [TM2] transgenes (#1 and #2) both caused higher levels of 
[TM2] in axon terminals and stronger rescue than the [TM1] transgene (Figures 2.10C, E-G). 
Strikingly, when we used 2 copies of the C4da-specific driver ppk-Gal4 to increase the axonal 
level of Dscam[TM1] to that expressed by Dscam[TM2] transgenes, the rescue effects were 
comparable (Figures 2.10C, D, F, and G). By quantitatively assessing transgenic Dscam::GFP 
levels in C4da axon terminals (Figure 2.10G), we found a linear correlation (R2=0.969) between 
presynaptic Dscam isoform levels and their rescue effects (Figure 2.10H). These results suggest 
that when localized in the same subcellular compartment, Dscam[TM1] function equally as 
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Dscam[TM2] in promoting axonal growth. Thus, the dendritic function of endogenous 
Dscam[TM1] is a result of its compartmentalized localization. 
 
Axonally enriched Dscam[TM2]-Dock signaling is essential for the axonal function of 
Dscam[TM2] 
While the study above demonstrates that the dendrite-specific localization of 
Dscam[TM1] prevents it from functioning in axon development, it remains unknown whether 
Dscam[TM1] and [TM2] exhibit any biochemical difference that might also explain the 
difference in their cellular functions. To test this possibility, we took advantage of isoTarget to 
compare Dscam[TM1] and [TM2] for their interactions with functional partners. Among the 
molecules known to bind to the intracellular domain of Dscam and mediate its signaling 
(Schmucker et al. 2000; Liu et al. 2009; Purohit et al. 2012; Kamiyama et al. 2015; Sterne, Kim, 
and Ye 2015b), we found that Dock, an SH2/SH3 adapter protein that is preferentially localized 
in axons (Hing et al. 1999; Desai et al. 1999; Fan et al. 2003), preferentially associated with 
Dscam[TM2] in Drosophila larval brains (Figure 2.11A). We further confirmed this finding with 
transgenic flies that overexpress Dscam[TM1]::GFP or [TM2]::GFP through their endogenous 
promoters (Wang et al. 2004a). Immunoprecipitation was performed using an anti-GFP antibody. 
Endogenous Dock preferentially co-precipitated with [TM2]::GFP from brain lysates of 3rd instar 
larvae (Figure 2.11B). Consistent with this notion, we found that Dock is required for 
Dscam[TM2] to promote axon terminal growth. While overexpressing [TM2] significantly 
promoted axon terminal growth in C4da neurons, its effect was completely eliminated by loss of 
dock (Figures 2.11C-G). Interestingly, we found that the [TM2]-Dock signaling is compartment-
dependent. Dock bound to both isoforms with equal affinity in cultured Schneider 2 (S2) cells, 
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which do not have dendrite-axon compartmentalization (Figure 2.11H). This result is consistent 
with the previous finding that the Dock-binding sites, including PXXP sites and polyproline 
motifs, are located in the cytoplasmic region shared by [TM1] and [TM2] (Schmucker et al. 
2000). Consistent with the biochemical results, the axon terminal overgrowth resulted from 
[TM1] overexpression was also eliminated by loss of dock (Figures 2.11I-L). Thus, given the 
same subcellular compartment, Dscam[TM1] and [TM2] are biochemically comparable and 
share the same signaling mechanism. Moreover, the ectopic localization, function and signaling 
of transgenic [TM1] in axons underscore the importance of studying splicing isoforms at 
physiological levels of expression. 
 
Axonal enrichment of Wnd compartmentalizes the Wnd-Dscam[TM2] signaling 
We showed previously that the signaling pathway involving the E3 ubiquitin ligase 
Highwire (Hiw) and the dual leucine zipper kinase Wallenda (Wnd) promotes Dscam expression 
(Kim et al. 2013). However, whether the Hiw-Wnd pathway regulates the expression of both 
[TM1] and [TM2] isoforms is unknown. To address this, we determined whether loss of hiw or 
overexpression of Wnd changed the levels of [TM1]::HA and [TM2]::V5. To test the effects of 
loss of hiw, Western blotting was performed on CNS lysates from trans-heterozygous 
[TM1]::HA / [TM2]::V5 larvae that were generated through global iso-Tagging. We found that 
loss of hiw led to increased expression of both Dscam[TM1] and [TM2] in the CNS (Figure 
2.12A). Next, we compared Wnd’s effect on the expression of Dscam[TM1] and [TM2]. As 
global overexpression of Wnd caused larval lethality, we co-expressed Wnd and R recombinase 
(for iso-Tagging of endogenous Dscam[TM1] and [TM2]) in a subset of CNS neurons with 
GAL44-77 (Kim et al. 2013). Interestingly, Wnd overexpression only increased the level of 
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Dscam[TM2] (Figure 2.12B), but not that of [TM1], suggesting that unlike Hiw, Wnd 
preferentially regulates the expression of Dscam[TM2]. This finding from biochemical studies 
was confirmed in C4da neurons by immunostaining of the endogenous Dscam[TM2] tagged 
through iso-Tagging. Immunostaining of Dscam[TM2]::V5iso-Tagging showed that endogenous 
Dscam[TM2] was undetectable in C4da axon terminals in 3rd-instar larvae, but detectable at this 
developmental stage when Wnd was overexpressed in these neurons (Figure 2.12C). 
Next, we investigated the mechanism underlying the differential effect of Wnd on 
Dscam[TM1] and [TM2]. Firstly, we determine whether Wnd is capable of increasing 
Dscam[TM1] expression in a cell type without the dendrite-axon compartmentalization.  We 
overexpressed Dscam isoforms with endogenous 5’ and 3’ UTR in S2 cells, and found that Wnd 
similarly promoted [TM1] and [TM2] expression (Figure 2.12D-E). This result suggest that 
Dscam[TM1] and [TM2] are molecularly indistinguishable for the Wnd regulation. Secondly, we 
identified the distribution of Wnd in neurons, and found that Wnd was enriched in axons but not 
dendrites. A GFP-tagged kinase-dead version of Wnd (GFP-WndKD)(Xiong et al. 2010) was 
expressed in C4da neurons; substantial signals were detected in axon terminals but not in 
dendrites (Figure 2.12F). These data suggest that axonal localization of Wnd compartmentalizes 
the Wnd-Dscam[TM2] signaling.  
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2.4 Discussion 
In this study, we developed isoTarget to generate splicing isoform-specific loss-of-
function mutants and conditional tagging in specific neurons. As a proof of concept, we applied 
isoTarget to investigate two mutually exclusive isoforms of Dscam, which differ in their 
transmembrane and juxtamembrane domains, for their subcellular localization, regulation of 
expression, function in dendrite/axon development, and subcellular signaling. These findings 
highlight the versatility of isoTarget and the importance of studying splicing isoform at 
endogenous levels in vivo. In addition, they establish the causality between the subcellular 
localization and cellular function of splicing isoforms, demonstrating the critical role of 
subcellular localization in expanding the functional diversity of splicing isoforms. 
Our study demonstrates that Dscam isoforms use two different modes to achieve distinct 
compartment-specific functions in vivo (Figure 2.12G). While the dendrite-specific localization 
restrains Dscam[TM1] from functioning in axons, axonal enrichment of functional partners 
forms a subcellular signaling pathway involving the ubiquitously distributed Dscam[TM2]. 
 
Subcellular localizations define the distinct cellular functions of alternative splicing 
isoforms that have the same biochemical functions 
Alternative isoforms often differ in their protein structures and thus the biochemical 
properties (Kelemen et al. 2013). Recent studies suggest the importance of subcellular 
localization in defining the cellular functions of alternative splicing isoforms. For example, in 
cultured neurons, the RBFOX1 gene generates a nuclear variant (by excluding exon 19) that 
regulates RNA splicing and a cytoplasmic variant (by including exon 19) that stabilizes mRNAs 
(Lee et al. 2016). However, whether subcellular localization causes the nuclear and cytoplasmic 
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variants differ in their cellular functions remains to be determined, as it is possible that the two 
isoforms have distinct biochemical functions. More broadly, a challenging question in the field is 
whether the difference in subcellular localization determines the compartmentalized functions for 
the isoform (i.e., the issue of causality), especially at the endogenous levels in vivo. By applying 
isoTarget in Drosophila sensory system, we establish the causality between the subcellular 
localization and cellular functions of the Dscam isoforms. Our findings highlight the critical role 
of subcellular localization in expanding the functional diversity of isoforms. 
 Even if they are localized in different subcellular compartments, splicing isoforms with 
the same biochemical function might exhibit the same cellular functions because their 
downstream partners might spread throughout the cell (e.g., via trans-compartmental 
communication (Terenzio, Schiavo, and Fainzilber 2017)). In order to achieve cellular functions 
specific to a compartment, one solution is to localize the functional partners shared by the 
isoforms to specific subcellular compartments. Indeed, we found that compartmental enrichment 
of interactors leads to isoform-specific signaling. The Dscam[TM1] and [TM2] do not differ in 
their biochemical interactions with Wnd and Dock (Figures 2.11H, 2.12C-D). Yet, the axonal 
enrichment of Wnd and Dock forms a compartmentalized Wnd-Dscam[TM2]-Dock signaling 
cascade in vivo, despite that Dscam[TM2] is present in both dendrites and axons (Figures 2.8C, 
E, H, K). These findings suggest that, for splicing isoforms with the same biochemical functions, 
specific cellular functions can be achieved by the compartment-specific colocalization of the 
isoforms and their functional partners (Figures 2.12G).  
 
Advantages of isoTarget 
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The studies reported in this paper demonstrate several advantages of isoTarget over 
traditional techniques. 
First, it can be used to generate classic genetic mutants for analyzing the functions of 
specific splicing isoforms. RNA interference has been adopted to investigate Dscam isoform 
functions in CNS neurons (Shi et al. 2007). However, we found that this method is not applicable 
for studying Dscam in larval PNS neurons (data not shown). This is likely because endogenous 
Dscam primarily functions at early developmental stages and a late efficacy of RNAi precluded 
the discovery of Dscam functions in these neurons. By contrast, isoTarget can be used to create a 
loss-of-function mutant a specific isoform without affecting other isoforms, allowing us to 
investigate the functions of Dscam isoforms in larval PNS neurons. 
 Second, isoTaget enables the identification of isoform-specific localization at the 
subcellular level in neurons of interest in vivo, which is otherwise challenging due to the 
difficulty in discerning immunofluorescent signals in subcellular compartments among a number 
of neurons expressing the same protein in the vicinity. In addition, this method expresses tagged 
proteins at more physiological levels than transgenes. Prior studies on Dscam have relied on 
transgenes to investigate the functions and subcellular localizations of Dscam[TM1] and [TM2] 
(Zhan et al. 2004; Wang et al. 2004a; Soba et al. 2007; Yang, Bai, and Lee 2008; Goyal et al. 
2019; Kim et al. 2013), but transgenic proteins are often ectopically localized. For example, 
whereas the endogenous Dscam[TM1] is absent in axons (Figures 2.8D and 2.9B), 
overexpressing [TM1] leads to its axonal localization (Figures 2.10A-G). In fact, tagging 
endogenous Dscam[TM1] and [TM2] with isoTarget led to the observation of consistent patterns 
of subcellular localization in different types of neurons (Figure 2.8), which reconciles the cell-
type discrepancies observed previously with transgenes. 
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 Third, isoTarget allows studying isoform-specific compartmentalized signaling. Using 
isoTarget, we identified a Wnd-Dscam[TM2]-Dock signaling pathway enriched at the 
presynaptic terminals of C4da neurons. Complementing the in vivo studies with isoTarget, we 
performed biochemical studies in S2 cells and found that Dscam[TM1] and [TM2] did not differ 
in their biochemical interactions with Wnd and Dock (Figures 2.11H, 2.12C-D). Consistent with 
this, forced localization of ectopic Dscam[TM1] in axons also increased axonal growth in vivo 
(Figures 2.10A-G) through the same downstream effector Dock used by Dscam[TM2] (Figures 
2.11I-L). In this series of studies, isoTarget was essential for establishing the cellular functions 
and biochemical interactions in vivo. 
  
Limitations 
There are three limitations to the isoTarget technique. First, for the successful application 
of isoTarget, the isoform inserted with iso-KO cassette is expected to lose its function. This is 
not necessarily always the case, especially when the targeted exon encodes a fragment located at 
the C-terminus of the protein. This problem is common in isoform studies by genetic 
modifications, including Cre-LoxP and isoEXPRESS (Gu et al. 2019). Developing isoform-
specific nanobody might be a way to solve this problem (Roth, Fulcher, and Sapkota 2019). 
Second, we discovered that the original translational stop cassette may cause off-target effects 
(Figures 2.5A-C and F), and that such effects depend on the length of the cassette. Thus, the 
expression of isoforms other than the targeted one should always be examined by techniques 
such as RT-qPCR. Finally, successful uses of isoTarget require that the epitope tagging 
preserves the function of the splicing isoform. Structural information would be helpful in 
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choosing the proper inserting site. For example, inserting the isoTarget cassette into the loop 
region of a polypeptide is likely to increase the chance of success. 
In summary, we have developed isoTarget as a versatile genetic tool that is compatible 
with a variety of techniques for analyzing isoform-specific properties and uncovering the 
mechanisms underlying isoform diversity at multiple levels in vivo. We anticipate this 
methodology be useful for isoform studies in various cell types and organisms. 
  
 
 
40 
 
2.5 Future directions 
Application of isoTarget in isoforms of other genes 
Here we successfully applied isoTarget to two Dscam isoforms. As few isoforms have 
been studies at endogenous and subcellular levels in vivo, there would be a rich list of candidate 
genes to target.  Notably, we found that the full-length tlstop cassette may alter the expression 
levels of other isoform in a length-dependent manner. Thus, we recommend the usage of short 
tlstop cassette in future studies.  
One interesting candidate is FoxP. The Foxp proteins are evolutionarily conserved 
transcription factors that are linked to a variety of human diseases, such as autism, speech 
disorders, tumor and autoimmune disease (Takahashi, Takahashi, and Liu 2009).  Though four 
members, FoxP1-P4, exist in humans, Drosophila exhibits a single ortholog, called FoxP. 
Drosophila FoxP is extensively expressed in the nervous system, including cholinergic, 
glutamatergic and GABAergic neurons (Castells-Nobau et al. 2019). It has been shown to play 
critical roles in pre and post-synaptic development, motor coordination, operant self-learning, 
perceptual decision and producing courtship songs (Castells-Nobau et al. 2019; Lawton, 
Wassmer, and Deitcher 2014; Mendoza et al. 2014; DasGupta, Ferreira, and Miesenbock 2014). 
Though it’s well known that 3 different isoforms exist in Foxp gene, whether these isoforms 
differ in their expression, localization and function remains a mystery. Application of isoTarget 
to FoxP isoforms is expected to advance the understanding to unprecedented levels.   
 
Application of isoTarget in conditional protein tagging 
Here we used the isoTarget cassettes to conditionally knockout and tag isoforms. In 
principle, these cassettes can be inserted to last exon before stop codon to conditionally tag 
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proteins. Compared with the commonly used transcriptional stop cassette, the translational stop 
cassette would not introduce exogenous 3’-UTR, which is critical for the expression, localization 
and post-translation modification of targeted genes. isoTarget cassettes can be widely used to 
examine the endogenous localization and signaling of targeted proteins at the endogenous and 
cell-specific levels in vivo. 
One potential direction is using isoTarget to conditionally tagging the endogenous 
receptors of neurotransmitters, such as GABA, acetylcholine, dopamine, serotonin and 
glutamate. Such a tool will be invaluable for assaying the subcellular localization of 
neurotransmitter receptor, the relative expression levels of receptor subunits, how neural 
circuitry and plasticity are regulated at certain cellular compartments. These results will 
significantly contribute to a more comprehensive and in-depth understanding of brain wiring in 
Drosophila. 
 
Dscam isoform levels may underlie the morphological diversity of neurons 
Drosophila neurons exhibit extensive diversity in the relative sizes of dendrite and axons. 
For example, lobula plate tangential cells (LPTCs), a family of giant neurons involved in visual 
feedback for self-motion, have remarkably large dendritic arbors and simple axons with short 
axon terminals (Wei et al. 2020). By contrast, Drosophila mushroom bodies, a neuronal 
ensemble critical for olfactory learning and memory, show long axonal arbors but relatively short 
dendrites (Heisenberg 2003). Despite these observations, the molecular mechanism underlying 
the morphological diversity is poorly understood.  
Here we discover that endogenous Dscam[TM1] function restrictedly in dendrites while 
[TM2] is responsible for axonal growth. These spatial differences raise the hypothesis that 
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neurons control morphogenesis by differentially manipulating the expression of Dscam[TM1] 
and [TM2]. Neurons with high Dscam[TM1]-to-[TM2] ratio exhibit extensive dendrites but short 
axons, while low Dscam[TM1]-to-[TM2] ratio corresponding to diminished dendrites but 
extensive presynaptic arborization. For example, in LPTC neurons, Dscam[TM1] may be highly 
expressed to ensure proper dendritic elaboration while [TM2] expression is restricted to 
guarantee small axon size. To test this hypothesis, it would be interesting to assay the association 
of Dscam[TM1]-to-[TM2] mRNA ratio with the relative dendritic/axonal arbor size in different 
neuronal types. With isoTarget fly lines at hand, LPTC neurons could be a good starting point. It 
would be exciting if endogenous Dscam[TM1] is highly expressed and transgenic 
overexpression of Dscam[TM2] confers aberrant long axons in LPTC neurons.  
Interestingly, mammalian Dscam are not alternatively spliced in the trans/juxta-
membrane region as Drosophila Dscam gene. How does a single form of Dscam protein 
potentially regulate the differential dendritic/axonal growth in distinct neuronal types in 
mammals? One possibility is that Dscam expression levels can be differentially controlled in 
dendrites versus axons. This could be achieved by molecular trafficking or local translation in 
targeted subcellular compartment. The other possibility is that despite of its even distribution, the 
subcellular localization of the Dscam downstream effectors or functional antagonizers confer 
differential function of Dscam signaling in different cellular compartments. Similar scenarios are 
observed in Drosophila sensory neurons by the finding of the axonal Wnd-Dscam[TM2]-Dock 
signaling. Applying isoTarget to conditionally tagging endogenous Dscam in targeted neuronal 
population in mouse model would be a key method to distinguish these two possibilities. 
 
Mechanisms underlying compartmentalized Wnd-Dscam[TM2] signaling 
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Our lab previously found that Wnd, the fly homolog of DLK, promotes Dscam 
expression levels via 3’UTR in the Drosophila brain. Here with isoTarget, we found wnd 
specifically promotes Dscam[TM2] expression at axon terminals of a neuron. As Wnd is 
enriched in axon terminals, one interesting question is whether this isoform-specific regulation 
depends on the axonal localization of Dscam[TM2] mRNA. As the mRNA difference between 
Dscam[TM1] and [TM2] is too short for fluorescent in situ hybridization (FISH), the traditional 
method is not feasible to answer this question. Here, isoTarget offers us one way to address this 
issue.  For example, we may specifically iso-Tag [TM2] in C4da neurons. As only axon 
terminals of C4 da neurons reach VNC, it’s expected to detect [TM2]::V5 mRNA by PCR if 
Dscam[TM2] is localized in axons.   
Another interesting question would be how Wnd, a MAP3K, promotes Dscam 
expression. We propose that the RNA binding protein (RBP) may be a go-between. As we found 
that this regulation is conserved in S2 cells, one experiment would be using Dscam[TM2]::GFP-
3’UTR as a reporter gene and carry out a systematic RNAi of RBPs with the presence of Wnd. 
One will be the candidate if knocking down the expression causes impaired Dscam[TM2]::GFP 
expression. Especially, it would be interesting to apply isoTarget to examine whether this RBP is 
specifically localized in axon terminals so that the compartmentalized Wnd-RBP-Dscam[TM2] 
signaling is caused by the presence of all three components. This observation will highlight the 
importance of subcellular localization in expanding signaling complexity in cells. 
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2.6 Author contribution 
H.L. and B.Y. conceived the project and designed the experiments. H.L. designed, generated and 
validated isoTarget flies, examined the functions, endogenous expression and signaling cascade 
of Dscam isoforms. S.P., R.L. and M.W.Z. performed MARCM on C4da neurons and assisted in 
quantification of global iso-KO. W.Z. examined isoform functions in C3da neurons. Y. H. 
assisted in generating isoTarget flies. L.Y. assisted in experiments of endogenous isoform 
expression. B.Y. supervised the project. H.L. and B.Y. wrote the paper. 
  
 
 
45 
 
2.7 Materials and methods 
Drosophila strains 
The following published fly strains were used: ppk-Gal4 (chromosome III) (Kuo, Jan, and Jan 
2005); GMR83B04-GAL4 (Pfeiffer et al. 2011); UAS-Dscam[TM2]::GFP (3.36.25, 
chromosome III and X), UAS-Dscam[TM1]::GFP (3.36.25, chromosome X), DscamP-
Dscam[TM1]::GFP (3.36.25) (Wang et al. 2004a), DscamP-Dscam[TM2]::GFP (3.36.25) (Wang 
et al. 2004a); OK107-Gal4 (Connolly et al. 1996); Dscam18 (Wang, Zugates, et al. 2002); hiwΔN 
(Wu et al. 2005); wnd1, wnd3, and UAS-Wnd (Collins et al. 2006); dock4732 and dockC506 (Garrity 
et al. 1996); nos-Gal4 (Van Doren, Williamson, and Lehmann 1998); 20xUAS-R recombinase 
(Nern et al. 2011). 
 
Generation of DNA constructs  
The design of isoTarget system is described in Figure S1A. The translational stop cassette was 
amplified by PCR from non-catalytic region of lacZ with frame shift to introduce multiple 
premature termination codons. The loxP-dsRed-loxP sequence is described in Gratz et al., (2014) 
(Gratz et al. 2014). The pBluescript donor plasmid, which contains isoTarget KI cassettes (GS 
linker-RSRT-tlstop-loxP-dsRed-loxP-RSRT-epitope-G3 linker) and Dscam isoform homologous 
sequences with mutated PAM, was generated with the In-Fusion HD Cloning Kit (Clontech 
Laboratories, Inc.). The pCFD3-dU63gRNA plasmid, which produces gRNA in fly embryos, is 
described in Ran et al., (2013) (Ran et al. 2013). The pUAST-Dscam5’UTR-
Dscam[TM1]::GFP-Dscam3’UTR (4.3-6.36-9.25) plasmid was made by modifying pUAST-
Dscam5’UTR- Dscam[TM2]::GFP-Dscam3’UTR (4.3-6.36-9.25)(Kim et al. 2013). Specifically, 
the fragment containing Dscam5’UTR and exons 1-16 and that containing exons 18-24 plus 
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Dscam3’UTR were amplified from pUAST-Dscam5’UTR- Dscam[TM2]::GFP-Dscam3’UTR by 
PCR. The fragments, together with PCR products of Dscam exon 17.1, were fused with the 
pUASTattB vector (linearized by EcoRV) by In-Fusion HD Cloning (Clontech Laboratories, 
Inc.). 
 
Sequences of isoTarget cassettes 
tlstop (in-frame stop codons that we introduced are underlined):  
TAACGTAAGCTAGCTAGACCGGTCCCAACTTAATCGCCTTGCAGCACATCCCCCTTT
CGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGC
GCAGCCTGAATGGCGAATGGCGCTTTGCCTGGTTTCCGGCACCAGAAGCGGTGCCG
GAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAAC
TGGCAGATGCACGGTTACGATGCGCCCATCTACACCAACGTAACCTATCCCATTACG
GTCAATCCGCCGTTTGTTCCCACGGAGAATCCGACGGGTTGTTACTCGCTCACATTT
AATGTTGATGAAAGCTGGCTACAGGAAGGCCACGCGTA 
 
Short tlstop (in-frame stop codons that we introduced are underlined):  
TAACGTAAGCTAGCTAGACCGGTTTCCCACGGAGAATCCGACGGGTTGTTACTCGCT
CACATTTAATGTTGATGAAAGCTGGCTACAGGAAGGCCACGCGTA 
 
GS-linker: GGTGGCGGCGGAAGCGGAGGTGGAGGCTCC 
RSRT: CTTGATGAAAGAATAACGTATTCTTTCATCAAG 
loxP: ATAACTTCGTATAATGTATGCTATACGAAGTTAT 
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dsRed box (consisting of 3XP3 enhancer/HSP70 promoter (Gratz et al. 2014), the cDNA 
encoding the dsRed fluorescent protein and SV40 3’ UTR) 
CGTACGGGATCTAATTCAATTAGAGACTAATTCAATTAGAGCTAATTCAATTAGGAT
CCAAGCTTATCGATTTCGAACCCTCGACCGCCGGAGTATAAATAGAGGCGCTTCGTC
TACGGAGCGACAATTCAATTCAAACAAGCAAAGTGAACACGTCGCTAAGCGAAAGC
TAAGCAAATAAACAAGCGCAGCTGAACAAGCTAAACAATCGGCTCGAAGCCGGTCG
CCACCATGGCCTCCTCCGAGGACGTCATCAAGGAGTTCATGCGCTTCAAGGTGCGCA
TGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCG
CCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGCGGCCCCCTGC
CCTTCGCCTGGGACATCCTGTCCCCCCAGTTCCAGTACGGCTCCAAGGTGTACGTGA
AGCACCCCGCCGACATCCCCGACTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGT
GGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCGTGACCCAGGACTCC
TCCCTcCAGGACGGCTCCTTCATCTACAAGGTGAAGTTCATCGGCGTGAACTTCCCCT
CCGACGGCCCCGTAATGCAGAAGAAGACTATGGGCTGGGAGGCgTCCACCGAGCGC
CTGTACCCCCGCGACGGCGTGCTGAAGGGCGAGATCCACAAGGCCCTGAAGCTGAA
GGACGGCGGCCACTACCTGGTGGAGTTCAAGTCCATCTACATGGCCAAGAAGCCCG
TGCAGCTGCCCGGCTACTACTACGTGGACTCCAAGCTGGACATCACCTCCCACAACG
AGGACTACACCATCGTGGAGCAGTACGAGCGCGCCGAGGGCCGCCACCACCTGTTC
CTGTAGGGGCCGCGACTCTAGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTG
CTTTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTT
GTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACA
AATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTAA
CCGGT 
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V5: GGCAAGCCCATCCCAAACCCACTGCTCGGCCTGGATAGCACC 
HA: TACCCATACGATGTTCCAGATTACGCT 
G3 linker (Gratz et al. 2014): GGTGGCGGC 
 
Generation of isoTarget flies 
The donor plasmid (750 ng/µl) and gRNA plasmid (250 ng/µl) were co-injected into fly embryos 
to generate mosaic G0 flies, which were crossed to white-/- flies to get G1 heterozygous knock-in 
flies that express the selection marker dsRed in their eyes. G1 flies with red fluorescence in their 
eyes were crossed to Cre-expressing flies (BL1092) to generate iso-KO flies. To generate global 
iso-Tagging flies, iso-KO flies were mated with the germline driver nos-Gal4 (BL4442) and 20x 
UAS-R recombinase (BL55795). According to our experiences, around 20% of fertile mosaic G0 
flies were able to generate G1 knock-in flies with fluorescent red eyes. The G1 knock-in flies 
constitute 1-30% of total G1 flies, depending on individual lines. To generate cell-type-specific 
iso-Tagging, iso-KO flies were mated with cell-type-specific Gal4 drivers, such as ppk-Gal4, and 
20x UAS-R recombinase. 
 
S2 cell culture and transfection 
S2 cells were maintained in Drosophila Schneider’s medium supplemented with 10% fetal 
bovine serum at 25°C in a humidified chamber. Plasmids were transfected into cultured S2 cells 
with polyethylenimine (PEI) (Ehrhardt et al. 2006). Cells were harvested for Western blotting 2 
days after transfection. 
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Co-immunoprecipitation and Western blotting 
To perform co-immunoprecipitation with neural tissues, the CNS of 3rd-instar larvae (∼120 per 
experimental condition) were dissected out and placed in ice-cold PBS containing 2 mM sodium 
vanadate. After a pulse of centrifugation, larval CNS were isolated and then lysed on ice with the 
lysis buffer (50 mM Tris-HCl/pH 7.4, 150 mM NaCl, 2 mM sodium vanadate, 10 mM sodium 
fluoride, 1% Triton X-100, 10% glycerol, 10 mM imidazole and 0.5 mM phenylmethylsulfonyl 
fluoride). Lysates were centrifuged at 15,000 g for 20 min at 4°C. The resulting supernatants 
were either saved as inputs or incubated with magnetic beads conjugated with appropriate 
antibodies for 4 hours at 4°C. After washing once with the lysis buffer, twice with lysis buffer 
containing 0.1% deoxycholate, and 3 times with lysis buffer lacking Triton X-100, the 
immunoprecipitates and total lysates were resolved on 7.5% SDS-PAGE gels followed by 
Western blotting as previously described (Kim et al., 2013). Protein samples were transferred to 
nitrocellulose membranes and detected by chemiluminescence (Catalog# 32106, Pierce ECL 
Western Blotting Substrate) with either a BIO-RAD ChemiDoc Touch Imaging system or a 
Kodak X-OMAT 2000 film processor. 
The procedure of co-immunoprecipitation with lysates from S2 cells was similar except 
that cultured S2 cells were re-suspended in ice-cold PBS before lysis. 
 
Imaging and image analysis 
Larvae immunostaining was described previously (Ye et al. 2011). Confocal imaging was done 
with a Leica SP5 confocal system with 20x or 63x glycerol immersion lenses. To minimize the 
variation, we only imaged neuronal dendrites and presynaptic terminals of C3da or C4da neurons 
in abdominal segments 4, 5, and 6. Images were collected with z stacks of 1-μm-step size for 
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dendrites and 0.3-μm-step size for axons. The resulting three-dimensional images were projected 
into two-dimensional images by maximum projection. The same imaging setting was applied 
throughout the imaging process. 
The Neurolucida software was used to quantify dendritic morphology and axon terminal 
growth. For dendrites, the overlap of sister branches is counted as a cross. For quantifying axon 
terminals of single C4 da neuron, branches shorter than 5 μm were excluded from the analysis. 
For quantifying the number of longitudinal axonal branches visible between abdominal segment 
4-6 (i.e., the connectives) of C4 da neurons, only complete connectives spanning neighboring 
segments were quantified. Fasciculated connectives are counted as two. 
To eliminate experimenter’s bias, these experiments were carried out in double-blind 
fashion. The images acquired by the primary experimenter were coded and randomized by 
another lab member. After the primary experimenter quantified the data, the data were decoded 
for statistical analysis. 
 
Reverse-transcription real-Time PCR 
The procedure was as described before (Kim et al., 2013). Briefly, mRNA was extracted from 
around 20 3rd-instar larval CNS with a standard Trizol method (Invitrogen). cDNA was 
synthesized with Invitrogen SuperScript III First-Strand Synthesis SuperMix (Invitrogen). 10 ng 
cDNA was used as the template for each real-time PCR reaction by SYBR Green mix (Thermo 
Scientific) with the Applied Biosystems 7300. To normalize Dscam transcripts to those of 
reference genes, we calculated Ct (Dscam) = Ct (Dscam) – Ct (reference gene). Statistical 
analysis was performed to compare Ct (Dscam)(wild-type) and Ct (Dscam)(mutant) to 
determine whether there is the expression of test gene is different between wild-type and mutants 
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(Yuan et al. 2006). Relative mRNA levels is calculated as: 2-Ct, where Ct (Dscam) = Ct 
(Dscam)(mutant) -Ct (Dscam)(wild-type). We used elav as the reference gene and Chmp1 as 
the internal control.  Following primers were used: Chmp1: 5’-
AAAGGCCAAGAAGGCGATTC-3’ and 5’-GGGCACTCATCCTGAGGTAGTT-3’; elav: 5’-
CTGCCAAAGACGATGACC-3’ and 5’-TAAAGCCTACTCCTTTCGTC-3’; Dscam[TM1]: 5’- 
CGTTACCGGAGGCACTATCG-3’ and 5’- ATCGTCTTTGTGGTGA TTGCC-3’; 
Dscam[TM2]: 5’- CGTTACCGGAGGCACCATT-3’ and 5’- ACTACATCG 
TAGTACACATCCTTT-3’. 
 
Statistical Analysis 
Data are presented as mean ± SEM. Comparisons of mean differences between groups were 
performed by One-way ANOVA followed by Student’s t-test. P < 0.05 was considered to be 
statistically significant. For all quantification, *: p < 0.05; **: p < 0.01; ***: p < 0.001; ns: not 
significant (p > 0.05). 
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Figure 2.1. Design of isoTarget and its application to studying the functional diversity of 
splicing isoforms. 
(A) Introducing translational stops into alternative exons allows isoform-specific manipulations 
of the gene. Inserting the commonly used transcriptional stop cassette into alternative exon leads 
to the transcriptional termination of all isoforms downstream of the targeted exon (left branch). 
In order to truncate the targeted isoform, but not the transcription or translation of the other 
isoforms (right branch), we engineered a translational stop (tlstop) cassette by introducing 
multiple stop codons into the DNA sequence encoding a non-catalytic region of β-Gal (bottom 
left).  
(B) Combining tlstop with other genetic methods for multi-purpose studies of the targeted 
splicing isoform. The isoTarget cassette, which consists of an RSRT site, a translational stop 
(tlstop), another RSRT site, and an epitope tag, is inserted into the targeted isoform exon by 
CRISPR/Cas9-mediated genome editing. The insertion generates a loss-of-function allele of 
either the targeted isoform or the entire gene, depending on the length of the tlstop cassette (see 
Figure S3F). Single cells that are homozygous for the targeted allele can be produced by genetic 
mosaic techniques, such as MARCM. The endogenous isoforms can be visualized in specific 
neurons by selective expression of R recombinase to remove the RSRT-tlstop-RSRT cassette. 
Expression of R recombinase in female germline cells leads to tagging of the isoform in all cells 
that express this isoform in the progeny (“global iso-tagging”). Expression of R recombinase in 
specific cell types or single cells leads to tagging of the isoform in those cells. In the iso-Tagged 
flies, upstream regulators and downstream effectors of specific isoforms can be identified 
through genetic, cell biological, and biochemical analyses. 
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Figure 2.2. The detailed design of the isoTarget cassette.  
(A) At the core of the cassette is a tlstop that contains multiple termination codons to ensure the 
disruption of mRNA translation. To achieve cell-type-specific labeling of targeted isoforms 
through inducible site-specific recombination, the tlstop is flanked by two RSRT sites followed 
by an epitope tag. To facilitate the screening of animals with successful integration of the 
isoTarget cassette, a transgene expressing dsRed under the 3xP3 enhancer/Hsp70 promoter is 
inserted in between the tlstop and the second RSRT site. The dsRed transgene is flanked by two 
loxP sites, allowing the removing of the dsRed in the presence of Cre recombinase. The 
isoTarget cassette can be knocked into the exon encoding the targeted isoform by CRISPR/Cas9.  
(B) The isoTarget insertion sites in Dscam[TM1] and [TM2] isoforms. Shown are the amino acid 
sequences encoded by the 17.1 (TM1) and 17.2 (TM2) exons. Red arrow heads indicate the 
insertion sites in the juxtamembrance regions.  
(C) Application of isoTarget to studying Dscam isoforms. As shown later, iso-KO of [TM1] 
impairs both [TM1] and [TM2] expression, and is thus named [TM1/2]iso-KO. We discovered a 
short tlstop cassette (“short iso-KO”) that specifically knocks out [TM1], but not [TM2]. Iso-
Tagging of Dscam[TM1] does not affect [TM1] functions. Iso-KO of [TM2] abolishes, while 
iso-Tagging preserves, Dscam[TM2] functions. Depending on the purpose of the experiment, 
Dscam[TM1] and [TM2] can be tagged either globally or specifically in targeted cell types. 
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Figure 2.3. isoTarget uncovers a specific role for the Dscam[TM2] isoform in axon terminal 
growth. 
(A-C) Compared with WT (A), global Dscam[TM2]iso-KO (B), but not Dscam[TM1]iso-KO (C), 
impairs axon terminal growth in C4da neurons. The C4da-specific driver ppk-Gal4 was used to 
label all C4da axon terminals in the CNS. Shown are representative images of abdominal 
segment 4 to 6 (A4-A6). The large red arrowheads point to the sites where longitudinal axon 
tracts are broken, and the small arrowheads point to where the tracts are thinned. 
(D-G) Dscam[TM2], but not [TM1], is required for the growth of axon terminals in single C4da 
neurons. The MARCM technique was used to generate single GFP-labeled C4da neurons that 
were homozygous of the indicated alleles. Dscam[TM1]iso-KO has no effect on axon terminal 
growth (D & E), while Dscam[TM2]iso-KO reduced the length of axon terminals to the same level 
as the loss of both isoforms (F & G). 
(H) Quantification of the number of axon connectives (i.e., the longitudinal branches) from A4 
to A6. Unless specified otherwise, mean ± SEM is shown in all figures, and the statistical tests 
are one-way ANOVA followed by Student’s t test. *: p < 0.05; **: p < 0.01; ***: p < 0.001; ns: 
not significant (p > 0.05). 
(I) Quantification of presynaptic terminal length in the C4da neuron ddaC. 
(J-M) Dscam[TM2], but not [TM1], is required for the growth of axon terminals in C3da 
neurons. The longitudinal axon tracts of C3da neurons in the CNS remain intact in 
Dscam[TM1]iso-KO (J & K), but are disrupted in Dscam[TM2]iso-KO (L) or in mutants lacking 
both isoforms (M). The large red arrow heads point to the sites where longitudinal axon tracts 
are broken. The small red arrowheads point to the sites where longitudinal axon tracts are 
thinned. 
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Figure 2.4. Validation of isoTarget in Dscam[TM2].  
(A) [TM2]iso-Tagging does not affect [TM2] functions. As shown in Figure 2A and B, [TM2]iso-KO 
impairs axon terminal growth in C4da neurons. The axonal defect is completely rescued in 
homozygous global [TM2]iso-Tagging larvae generated by excision of the RSRT-tlstop-RSRT box 
from the iso-KO. Shown are the C4da axon terminals in A4-A6 segments. 
(B) Quantification of the number of C4da axon connectives. 
(C) Neither global [TM2]iso-KO nor homozygous global [TM2]iso-Tagging affect the mRNA levels of 
Dscam[TM1]. mRNAs from the whole CNS of 3rd instar larvae were used for reverse-
transcription real-time PCR. The Ct value of [TM2] mRNA is normalized to that of elav gene 
as descried in the Experimental Procedure. Chmp1 serves as the internal control. Each dot 
represents one independent experiment. 
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Figure 2.5. Validation of isoTarget in Dscam[TM1] and the discovery of short tlstop 
cassette.  
(A) Dscam[TM2] mRNA is undetectable in global Dscam[TM1] isoTarget flies resulted from the 
insertion of the original long tlstop cassette (“[TM1/2]iso-KO”), but remains intact in global 
Dscam[TM1] isoTarget flies generated by the insertion of the short tlstop cassette (“[TM1]iso-
KO”). Dscam[TM2] mRNA level is not affected in homozygous global [TM1]iso-Tagging larvae. 
mRNAs from the whole CNS of 3rd instar larvae were used for reverse-transcription real-time 
PCR.  
(B-E) Immunostaining of the CNS with an anti-Dscam antibody shows that while Dscam 
expression is abolished in global Dscam[TM1/2]iso-KO (C), it is detectable in global 
Dscam[TM2]iso-KO (D) and exhibits a pattern that is similar to endogenous Dscam[TM2] labeled 
by global [TM2]::V5 iso-Tagging (E). 
(F) A schematic model of TM exon selection from Dscam pre-mRNA, based on a previous study 
(Anastassiou, Liu, and Varadan 2006). The complementary sequences (green) form a stem-loop, 
which is required for the selection of TM2 exon into Dscam mRNA. Inserting a long cassette 
into TM1 exon may create a long distance that eliminates TM2 exon selection.   
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Figure 2.6. isoTarget uncovers redundant functions for Dscam[TM1] and [TM2] in 
dendrite self-avoidance. 
(A-D) Dscam[TM1] and [TM2] function redundantly in mediating dendritic self-avoidance in 
C3da neuron. In 3rd instar larvae, C3da dendrites rarely fasciculate or intersect with each other in 
wild-type (WT) (A), while loss of both Dscam[TM1] and [TM2] isoforms (Dscam[TM1/2]iso-KO) 
significantly impairs self-avoidance (B). Loss of either Dscam[TM1] (C) or [TM2] (D) does not 
affect dendritic self-avoidance. The red arrows point to dendritic crossing sites. 
(E) Quantification of dendritic branch crossings in the C3da neuron ddaF. 
(F-I) Dscam[TM1] and [TM2] function redundantly in mediating dendritic self-avoidance in 
C4da neurons. The MARCM technique was used. Small red arrows point to crossings of fine 
dendritic branches, and large red arrows point to crossings of major dendritic branches, which is 
only observed when both isoforms are lost. 
(J) Quantification of dendritic branch crosses in the C4da neuron ddaC. 
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Figure 2.7. Dscam[TM1] and [TM2] function redundantly in mediating dendritic self-
avoidance in C4da neurons. 
(A-D) While Dscam[TM1/2]iso-KO (B) increases the crossing of dendritic branches in C4da 
neurons in 3rd instar larvae, neither Dscam[TM1]iso-KO nor Dscam[TM2]iso-KO impairs dendritic 
self-avoidance (C & D). Small red arrows point to crossings of fine dendritic branches, and large 
red arrows point to crossings of major dendritic branches, which is only observed when both 
isoforms are lost.  
(E) Quantification of dendritic branch crosses in the C4da neuron ddaC. 
  
 
 
64 
 
 
  
 
 
65 
 
Figure 2.8. Using isoTarget to identify the subcellular localizations of endogenous Dscam 
isoforms. 
(A-C) Both Dscam[TM1] and [TM2] are localized in the dendrites of larval PNS neurons. At 
early 2nd instar stage, compared with control (A), global iso-Tagging reveals the localization of 
endogenous [TM1] and [TM2] in the dendrites of PNS da neurons, which is double-labeled by 
the PNS neuron marker anti-HRP. 
(D & E) iso-Tagging shows that endogenous Dscam[TM2], but not [TM1], is in the axon 
terminals of C4da neurons in early 2nd instar larvae. The C4da-specific driver ppk-Gal4 was used 
to tag endogenous Dscam[TM1] or [TM2] by driving the expression of UAS-R-recombinase and 
to label C4da axon terminals by driving the expression of UAS-mCD8::RFP. 
(F-H) Both Dscam[TM1] and [TM2] are localized in the dendrites of CNS neurons. Iso-Tagging 
in mushroom body neurons shows that both endogenous [TM1] and [TM2] are present in MB 
calyx, which is a cluster of dendrites in 3rd instar larvae. The MB driver OK107-Gal4 was used 
to drive the expression of R recombinase for tagging endogenous Dscam[TM1] or [TM2] and the 
expression of mCD8::RFP for labeling MB morphology. 
(I-K) Dscam[TM2], but not [TM1], is localized in MB axons. Compared to the WT control, 
endogenous Dscam[TM2], but not [TM1], is detected in the axon peduncles of MB in 3rd instar 
larvae. 
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Figure 2.9. Endogenous Dscam[TM2], but not [TM1], is localized in axons connecting the 
CNS and PNS.  
Endogenous Dscam[TM1] is observed in VNC neuropil region, but not in axonal shafts. By 
contrast, endogenous Dscam[TM2] is localized in axon shafts besides the VNC neuropil. The 
insets are magnified views of the boxed regions. 
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Figure 2.10. Dendrite-specific localization restrains endogenous Dscam[TM1] from 
functioning in axons. 
(A) Dscam[TM2]iso-KO dramatically impairs the axon terminal growth in C4da neurons. The large 
red arrowheads point to the sites where longitudinal axon tracts are broken, and the small 
arrowheads point to where the tracts are thinned. 
(B) Overexpression of a Dscam[TM1] transgene with a single copy of ppk-Gal4 leads to a low 
level of [TM1] in axon terminals and mitigates the axonal defect in [TM2] iso-KO. 
(C) Overexpression of the Dscam[TM2]#1 transgene with a single copy of ppk-Gal4 also 
mitigates the axonal defect in [TM2] iso-KO. 
(D) When the Dscam[TM1] transgene is driven by 2 copies of ppk-Gal4, it leads to higher levels 
of [TM1] in axon terminals than the overexpression driven by one copy of ppk-Gal4 and rescue 
effects that are comparable with [TM2] overexpression. 
(E) Overexpression of the Dscam[TM2]#2 transgene with a single copy of ppk-Gal4 leads to 
higher levels and rescue effects than that of [TM1] in C4da axon terminals. 
(F) Quantification of the number of C4da axon connectives in segments A4-A6.  
(G) Quantitation of transgenic Dscam::GFP levels in C4da axon terminals. The experiments 
were done in Dscam[TM2]iso-KO larvae. As shown in the schematic (top, green drawings), UAS-
Dscam::GFP transgenes were expressed in C4da neurons with the ppk-Gal4 driver. VNCs 
(indicated by the dashed red box in the top panel), which contained transgenic Dscam::GFP in 
C4da axon terminals, were dissected out from 3rd instar larvae for Western blotting. The bottom 
panel shows the Western blots of transgenic Dscam::GFP in the axon terminals of C4da neurons. 
The VNC lysates were used for Western blotting with anti-GFP and anti-Elav antibodies. The 
relative expression levels are GFP signals normalized by Elav signals. Each dot represents the 
result from one independent experiment. Overexpression of a [TM1] transgene resulted in a 
modest level of [TM1] in axon terminals, while two different [TM2] transgenes caused higher 
levels of [TM2] in axon terminals. Two copies of ppk-Gal4 increased the levels of [TM1] in 
axon terminals. 
(H) The rescue of the axonal defect caused by loss of Dscam is proportional to the level of 
transgenic Dscam in C4da axon terminals, regardless of the isoform. The relative Dscam 
expression levels were determined by Western blotting of CNS lysates from larvae 
overexpressing [TM1]::GFP or [TM2]::GFP by ppk-Gal4 and plotted against the rescue effect of 
the transgene. 
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Figure 2.11. Dscam[TM1] and [TM2] exhibit similar biochemical properties and cellular 
functions when they are localized in the same subcellular compartment.  
(A & B) Dock preferentially interacts with endogenous Dscam[TM2] in vivo. (A) Brain lysates 
of larvae with global iso-Tagging of [TM1]::HA or [TM2]::V5 were immunoprecipitated by anti-
HA or V5 beads, respectively, and immunoblotted with an anti-Dscam antibody that recognizes 
both [TM1] and [TM2] and an anti-Dock antibody. This experiment was repeated twice 
independently. (B) Brain lysates of larvae that expressed [TM1]::GFP or [TM2]::GFP through 
the endogenous Dscam promoter were immunoprecipitated by an anti-GFP antibody. The 
immunoprecipitates were immunoblotted with anti-GFP and anti-Dock antibodies. This 
experiment was repeated three times independently. 
(C-F) Dscam[TM2] requires Dock to promote presynaptic terminal growth. Shown are 
representative images of A4-A6. Overexpressing a Dscam[TM2]::GFP transgene significantly 
promotes axonal growth in C4da neurons (C & D). While loss of dock does not affect C4da axon 
terminals (E), it completely abolishes the overgrowth caused by Dscam[TM2]::GFP 
overexpression (F). 
(G) Quantification of the number of C4da axon connectives. 
(H) Dock binds to [TM1] and [TM2] in similar affinity in cultured S2 cells. Lysates of S2 cells 
expressing mCD8::GFP, Dscam[TM1]::GFP or [TM2]::GFP were immunoprecipitated with an 
anti-GFP antibody. Inputs and immunoprecipitates were blotted by anti-GFP and anti-Dock 
antibodies. This experiment was repeated three times independently. 
(I-K) Transgenic Dscam[TM1] requires Dock to promote presynaptic terminal growth. 
Compared to WT (I), overexpressing [TM1]::GFP transgene significantly promotes axonal 
growth in C4da neurons (J), which is completely abolished by loss of dock (K). 
(L) Quantification of the number of C4da axon connectives from A4-A6. 
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Figure 2.12. Axonal enrichment of Wnd compartmentalizes Wnd-Dscam[TM2] signaling.  
(A) Hiw suppresses the expression of both Dscam[TM1] and [TM2]. In the brains of 3rd instar 
larvae that were trans-heterozygotes of global iso-Tagging of [TM1]::HA and [TM2]::V5, loss of 
hiw (hiwΔN) elevated the levels of both endogenous [TM1] and [TM2]. Left: Western blots; 
Right: quantification of Western blots. Each dot represents the result from one independent 
experiment. 
(B) Overexpression of Wnd increases the levels of Dscam[TM2], but not that of [TM1]. Top: 
The Gal44-77, which is expressed in a small set of PNS neurons and a number of CNS neurons, 
was used to drive the expression of R recombinase for iso-Tagging and the overexpression of 
Wnd. Compared with a kinase-dead Wnd transgene (WndKD), overexpressing Wnd does not 
affect endogenous Dscam[TM1] levels (left), but significantly increases Dscam[TM2] levels 
(right) in 3rd-instar larval brains. Bottom: quantification of Western blots. Each dot represents the 
result from one independent experiment. 
(C) Overexpression of Wnd increases endogenous Dscam[TM2] levels in the presynaptic 
terminals of C4da neurons. At the 3rd instar larval stage, Dscam[TM2]::V5iso-Tagging is no longer 
detectable in C4da axon terminals. Overexpression of Wnd elevates the level of 
Dscam[TM2]::V5iso-Tagging in these terminals. 
(D, E) Wnd similarly promotes [TM1] and [TM2] expression in cultured S2 cells. S2 cells are 
transfected with plasmids expressing Wnd and [TM1]::GFP or [TM2]::GFP with endogenous 
Dscam 5’ and 3’ UTR. Lysates of S2 cells were blotted by anti-GFP and anti-tublin antibodies. 
Each dot represents the result from one independent experiment. 
(F) Wnd is enriched in axons. GFP-tagged kinase-dead Wnd (GFP::WndKD) was expressed in 
C4da neurons by ppk-Gal4. mCD8::RFP was used to label the neurons. While GFP::WndKD 
signal is enriched in axon terminals, little is observed in dendrites. Yellow arrows point to major 
dendritic branches. 
(G) Subcellular localization expands the functional diversity of splicing isoforms via two 
different modes. In Mode 1, the localization of an isoform in a particular subcellular location 
(e.g., Dscam[TM1] in dendrites) restrains this isoform from functioning in other compartments. 
In Mode 2, the enrichment of the functional partners (e.g., Wnd and Dock) for a ubiquitously 
localized isoform (e.g., Dscam[TM2]) leads to isoform-specific subcellular signaling and 
functions. 
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Chapter 3 
Dscam Gene Triplication Causes Neocortical Overinhibition in  
Down Syndrome 
 
This chapter is modified after a research article that is under revision for publication with authors 
listed as Hao Liu, René N. Caballero-Florán, Tao Yang, Jacob M. Hull, Geng Pan, Ruonan Li, 
Macy Veling, Lori L. Isom, Kenneth Y. Kwan, Z. Josh Huang, Peter G. Fuerst, Paul M. Jenkins 
and Bing Ye. 
 
3.1 Abstract  
A growing number of molecules have been identified as regulators of inhibitory synapse 
development, but whether dysregulated expression of these molecules contribute to brain 
disorders is poorly understood. Here we show that Down syndrome cell adhesion molecule 
(Dscam) regulates the inhibition of neocortical pyramidal neurons (PyNs) in a level-dependent 
fashion. Loss of Dscam impairs inhibitory neuron development and function. In the Ts65Dn 
mouse model for Down syndrome, where Dscam is overexpressed, GABAergic innervation of 
cortical PyNs by chandelier and basket cells is increased. Genetic normalization of Dscam 
expression rescues the excessive GABAergic innervation and the increased inhibition of PyNs. 
These findings demonstrate excessive GABAergic innervation and inhibition in the neocortex of 
Down syndrome mouse model and identify Dscam overexpression as the cause. They also 
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implicate dysregulated Dscam levels as a potential pathogenic driver in related neurological 
disorders. 
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3.2 Introduction  
GABAergic neurons mediate synaptic inhibition in the mammalian brain (Tremblay, Lee, 
and Rudy 2016; Lim et al. 2018), and altered GABAergic inhibition has emerged as a nexus of 
circuit dysfunction in a number of neurodevelopmental disorders (Chattopadhyaya and Cristo 
2012; Ramamoorthi and Lin 2011). A growing number of molecules have been identified in 
GABAergic synapse formation and synaptic transmission (Ko, Choii, and Um 2015; 
Ramamoorthi and Lin 2011; Dalva, McClelland, and Kayser 2007; de Wit and Ghosh 2016; 
Krueger-Burg, Papadopoulos, and Brose 2017; Sudhof 2018). Intriguingly, copy number 
variations of these genes are commonly found in different neurological diseases (Ko, Choii, and 
Um 2015), suggesting that dysregulated expression of these genes might be a pathogenic driver. 
However, whether or not this is true remains largely unknown. 
Down syndrome cell adhesion molecule (Dscam) is an evolutionarily conserved type I 
transmembrane protein (Yamakawa et al. 1998). In humans, Dscam gene is localized in the 
Down syndrome critical region on chromosome 21 (hCh21) (Yamakawa et al. 1998). We 
previously showed in Drosophila that Dscam protein levels determine the sizes of presynaptic 
terminals without requiring the ectodomain diversity of the Drosophila Dscam gene (Kim et al. 
2013). Moreover, others reported that overexpression of Dscam impairs synaptic targeting and 
transmission in Drosophila (Cvetkovska et al. 2013; Lowe, Hodge, and Usowicz 2018). These 
findings suggest that dysregulated Dscam levels might contribute to neuronal defects in brain 
disorders. In fact, altered Dscam expression levels have been reported in multiple brain 
disorders, including Down syndrome (DS) (Saito et al. 2000), autism spectrum disorders (ASD) 
(O'Roak et al. 2014; Krumm et al. 2015; Turner et al. 2016), intractable epilepsy (Shen et al. 
2011), bipolar disorder (Amano et al. 2008), and possibly Fragile X syndrome (Brown et al. 
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2001; Darnell et al. 2011; Kim et al. 2013; Cvetkovska et al. 2013). Although recent findings 
suggest a conserved role of Dscam in promoting presynaptic growth in vertebrates (Santos et al. 
2018; Bruce et al. 2017), whether dysregulated Dscam expression results in neuronal defects in 
brain disorders remains unknown.  
In this work, we sought to determine the effects of altered expression levels of Dscam in 
mouse models of DS, in which the Dscam gene is triplicated. Previous studies have shown that 
enhanced GABAergic inhibition impairs cognition in Ts65Dn mice (Fernandez et al. 2007; Colas 
et al. 2013b; Braudeau, Dauphinot, et al. 2011; Braudeau, Delatour, et al. 2011; Martinez-Cue et 
al. 2013), the most widely used DS animal model (Reeves et al. 1995; Rueda, Florez, and 
Martinez-Cue 2012). A series of studies have demonstrated excessive GABAergic inhibition in 
the hippocampus of Ts65Dn mice (Fernandez and Garner 2008; Kleschevnikov, Belichenko, 
Faizi, et al. 2012; Kleschevnikov, Belichenko, Gall, et al. 2012; Kleschevnikov et al. 2004; Costa 
and Grybko 2005; Siarey et al. 1997; Fernandez et al. 2007; Contestabile, Magara, and Cancedda 
2017; Haydar and Reeves 2012; Chakrabarti et al. 2010). However, whether GABAergic 
signaling is altered in other brain regions and, if it is, what genes on hCh21 cause it, are poorly 
understood. Here, by combining recently developed genetic tools for sparse labeling and whole-
cell patch-clamp, we found excessive GABAergic innervation and inhibition of PyNs by 
chandelier (ChC) and basket cells in the neocortex of Ts65Dn mice. Genetic normalization of 
Dscam expression levels rescued the presynaptic overgrowth and excessive synaptic 
transmission of GABAergic neurons. Consistently, loss of Dscam impaired ChC presynaptic 
terminals and reduced GABAergic inhibition of neocortical PyNs. In addition, we found that 
ChC axon terminal growth and synaptogenesis are coupled and positively correlated with 
neocortical Dscam levels in both wide-type and Ts65Dn mice. These findings uncover novel 
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molecular, cellular and synaptic mechanisms for DS brain disorders and highlight the critical role 
of Dscam levels in regulating neocortical inhibition. Dysregulated Dscam expression levels may 
be a common contributor to GABAergic dysfunctions in associated neurological diseases. 
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3.3 Results  
Loss of Dscam impairs ChC presynaptic development in mice 
To determine whether Dscam regulates GABAergic neuron development in the 
neocortex, we focused the analysis on ChCs for two reasons. First, ChCs are thought to be the 
most potent inhibitory neurons in the neocortex (DeFelipe 1999). Each ChC innervates roughly 
two hundred PyNs at their axon initial segments (AIS) (Blazquez-Llorca et al. 2015), where 
action potentials are generated (Szentagothai 1975b; Jones 1975). Second, the morphology of 
ChCs is relatively stereotypical and reliably quantifiable (Fazzari et al. 2010; Tai et al. 2014; 
Favuzzi et al. 2019; Yang et al. 2018). We specifically label single ChCs in the neocortex by 
crossing the Nkx2.1-CreER mouse line with the tdTomato reporter line Ai14 (Taniguchi, Lu, and 
Huang 2013)(Figure 3.1A). A single ChC extends only a few dendritic branches but several 
hundreds of presynaptic terminals, called axonal cartridges, each of which innervates one or two 
PyNs (Inan and Anderson 2014). The axonal cartridges and presynaptic boutons of single ChCs 
were quantified in a three-dimensional volume defined based on the position of ChC cell body 
(Figure 3.2). AIS-colocalized cartridges and presynaptic boutons were quantified, as off-target 
varicosities lack presynaptic markers and symmetric synaptic densities (Steinecke et al. 2017). 
The AIS was immunolabeled by an anti-phospho-IκB antibody (pIκB) (Taniguchi, Lu, and 
Huang 2013; Lu et al. 2017; Tai et al. 2014; Fazzari et al. 2010), which strongly correlates with 
the AIS labeled by ankyrin-G antibodies in the mouse neocortex (Buffington et al. 2012) (Figure 
3.3). Quantification was performed in a double-blinded fashion to avoid experimenters’ bias. The 
ChCs in the cortical layer II and III of the anterior cingulate cortex (ACC) were analyzed as the 
morphology of ChCs in this region is most stereotypical. Mice were analyzed on postnatal day 
28 (P28), a time after ChC development is complete (Inan and Anderson 2014). 
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Similar to its role in presynaptic development in Drosophila, loss of Dscam significantly 
impeded the development of ChC presynaptic terminals (Figures 3.1B-E). Compared to 
heterozygous littermates, the number and length of individual cartridges were significantly 
reduced in Dscam-/- mice by 8% and 12%, respectively, so that the total cartridge length for each 
ChC was reduced by 23% (Figures 3.1C-E). Moreover, the numbers and sizes of presynaptic 
boutons were significantly reduced by 20% and 16%, respectively (Figures 3.1F-H). 
Interestingly, no difference was observed in the interbouton distance between these two groups 
(Figure 3.4A), indicating that Dscam does not regulate bouton density. These results demonstrate 
that Dscam is required for ChC presynaptic development in mice. 
 
Loss of Dscam impaired GABAergic inhibition of PyNs 
To determine whether defective GABAergic synaptogenesis caused by loss of Dscam 
impairs GABAergic synaptic transmission, whole-cell patch-clamp was applied to record PyNs 
in layers II/III of the ACC from acute neocortical brain slices. Consistent with impaired axonal 
growth and synaptogenesis in ChCs, we found that the average frequency of miniature inhibitory 
postsynaptic currents (mIPSCs) was ~35% less in Dscam-/- mice than that in heterozygous 
littermates (Figures 3.5A-B). In addition, the average amplitude of mIPSCs was 42% less, -
suggesting that postsynaptic responses were impaired by loss of Dscam (Figures 3.5A and C). 
Similar changes were observed in the frequency and amplitude of spontaneous IPSC (sIPSCs) 
(Figures 3.5D-F). 
Consistent with the reduced GABAergic transmission, we observed hyperactivity in 
neocortical PyNs, as indicated by c-fos expression levels (Herrera and Robertson 1996). There 
was 5-fold more c-fos-positive PyNs in Dscam-/- than in Dscam+/- mice (Figures 3.5G-H). 
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Taken together, these data suggest that Dscam is required for the normal level of inhibition of 
PyNs in the neocortex. 
 
ChCs exhibit excessive presynaptic terminals and boutons in Ts65Dn mice 
Next, we determined whether the presynaptic development of ChCs is altered in the 
Ts65Dn mouse model of DS, where Dscam is present in 3 copies (Reeves et al. 1995) and 
overexpressed (Figure 3.6). Compared to euploid littermates, the number and length of 
individual axonal cartridges were significantly increased in Ts65Dn mice by 28% and 11%, 
respectively (Figures 3.7A-C). The total cartridge length, which is the sum of individual 
cartridges in the quantified volume, was increased by 37% (Figure 3.7D). In addition, ChC 
showed a significant increase in both the number and size of synaptic boutons in Ts65Dn mice. 
The bouton number for each ChC is increased by 36% (Figures 3.7E-F). The average size of 
presynaptic boutons was enlarged by 21% (Figures 3.7E and G). The increased ChC presynaptic 
bouton number and size are consistent with previous reports of increased number of the puncta 
positive of vesicular GABA transporter proteins (VGAT) and enlarged inhibitory synapses in the 
neocortex of Ts65Dn mice (Kurt et al. 2000; Nosheny et al. 2015). The average interbouton 
distance between neighboring boutons showed a significant, though subtle, decrease in the 
trisomy mice (Figure 3.4B), suggesting a slight increase in bouton density. Altogether, by 
labeling and quantifying single interneurons in the ACC, we found excessive presynaptic 
terminals and boutons in Ts65Dn mice, which is opposite of what we observed in Dscam-/- 
mice. 
 
Normalization of Dscam levels rescues ChC presynaptic overgrowth in Ts65Dn mice 
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Dscam is overexpressed in both the brains of DS patients and those of Ts65Dn mouse 
model of DS (Saito et al. 2000) (Figure 3.6). Previous studies in Drosophila have demonstrated 
that increased levels of Dscam lead to excessive growth of presynaptic terminals (Kim et al. 
2013; Sterne, Kim, and Ye 2015b). To determine whether the overexpressed Dscam in Ts65Dn 
mice causes presynaptic overgrowth in ChCs, we normalized Dscam gene dosage in Ts65Dn 
mice by crossing female Ts65Dn mice with male Dscam+/- mice to obtain the 
Ts65Dn:Dscam+/+/- genotype (Figure 3.8A). This genetic scheme also yielded regular Ts65Dn 
littermates (Ts65Dn:Dscam+/+/+). In Ts65Dn mice with two copies of functional Dscam genes, 
the average levels of Dscam proteins were statistically indistinguishable from the euploid mice 
(Figure 3.8B). 
Normalizing Dscam levels rescued ChC presynaptic overgrowth in Ts65Dn mice. 
Compared with Ts65Dn littermates, the ChC cartridge number, individual cartridge length and 
total cartridge length were reversed to levels indistinguishable from euploid in 
Ts65Dn:Dscam+/+/- mice (Figures 3.8C-F). In addition, the increased bouton number and 
bouton size were mostly rescued by normalizing Dscam expression (Figures 3.8G-I), while no 
change was observed in the interbouton distance (Figure 3.4B). These results demonstrate that 
ChC presynaptic terminal overgrowth is mainly caused by Dscam overexpression in Ts65Dn 
mice. 
 
ChC axon terminal growth and synaptogenesis are positively coupled 
Presynaptic terminal growth and synaptogenesis are concurrent processes for forming 
proper neuronal connections (Javaherian and Cline 2005). Little is known about whether and 
how these two events are orchestrated in mammalian GABAergic interneurons. The sparse 
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labeling of ChCs offers an opportunity to address these questions at the single-cell resolution. 
We examined the relationship between cartridge length and three morphological aspects of 
synaptic boutons, namely bouton number, size, and density (as reflected by the interbouton 
distance), in single ChCs. We found a strong correlation between the cartridge length and the 
bouton number of each ChC in both wild-type (euploid) (R2 = 0.82, p < 10-7) and Ts65Dn mice 
(R2 = 0.79, p < 10-15) (Figure 3.9A). Although Dscam positively regulated both cartridge length 
and bouton number (Fig. 3.1E, G and Fig. 3.8F, H), loss of Dscam did not impair their coupling 
(R2 = 0.89, p < 10-8) (Figure 3.9B). There was also a significant correlation between cartridge 
length and bouton size in both wild-type and Ts65Dn mice (Figure 3.9C), though it was weaker 
than that between cartridge length and bouton number. Loss of Dscam seemed to mildly impair 
the coupling between cartridge length and bouton size (Figure 3.9D). There was no correlation 
between cartridge length and bouton density in any of the genotypes tested (Figures 3.9E and F). 
Taken together, these results suggest that presynaptic terminal growth and synaptogenesis are 
positively coupled in ChC development. 
 
ChC presynaptic cartridge length and synaptogenesis are proportional to neocortical 
Dscam levels 
In Drosophila, Dscam levels determine the size of presynaptic arbors (Kim et al. 2013). 
Western blotting results suggested that Dscam levels in the neocortex exhibited individual 
variations in euploid, Ts65Dn, and Ts65Dn:Dscam+/+/- mice (Figure 3.8B and 3.10A). We 
plotted the neocortical Dscam level of each mouse, as assayed by western blotting, against the 
average cartridge length, bouton number, size or density in each mouse. We observed a strong 
correlation between Dscam levels and cartridge lengths, bouton number and bouton sizes in mice 
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(Figures 3.10B-D). In contrast, no correlation was found between Dscam levels and interbouton 
distance (Figure 3.10E), again supporting that bouton density is not regulated by Dscam (Figures 
3.4A-B). The dosage-dependence highlights the importance of Dscam expression levels in 
regulating ChC presynaptic development. 
 
Dscam overexpression increases the number of GABAergic synapses on PyN somas in 
Ts65Dn mice 
Dscam is expressed in different subtypes of GABAergic neurons (Paul et al. 2017). Does 
its overexpression in Ts65Dn mice cause developmental defects in other types of GABAergic 
neurons? Basket cells are the most common cortical interneurons that preferentially innervate the 
somas of PyNs (Tremblay, Lee, and Rudy 2016; Lim et al. 2018). Because basket cell 
morphology is highly heterogeneous (Wang, Gupta, et al. 2002), we analyzed the GABAergic 
synapses formed by basket cells on PyN soma (i.e., perisomatic synapses), rather than 
quantifying the morphology of single basket cells as we did on ChCs. To visualize perisomatic 
GABAergic synapses, brain sections were triply labeled with anti-Bassoon (for presynaptic 
active zone) (Dieck et al. 1998), anti-VGAT (for presynaptic GABAergic boutons) (Chaudhry et 
al. 1998), and anti-GRASP1 (for PyN soma and proximal dendrites) (Ye et al. 2000). Most 
Bassoon+ puncta around a PyN soma were surrounded by or overlapped with VGAT signals 
(Figure 3.11A). We found that the average number of GABAergic synapses around each PyN 
soma—as indicated by Bassoon+ puncta that were either apposed to or overlapped with VGAT+ 
signals—was 20% more in Ts65dn neocortices than euploid controls (Figures 3.12A-B). 
Strikingly, normalizing Dscam expression level completely rescued the enhanced synaptogenesis 
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(Figures 3.12B-D). These data suggest that the overexpressed Dscam in Ts65Dn mice also 
increases the number of GABAergic synapses on PyN somas. 
 
Normalizing Dscam levels rescues the excessive GABAergic synaptic transmission in the 
Ts65Dn neocortex 
Previous studies in Ts65Dn neocortices have demonstrated enhanced GABAergic 
neurogenesis (Chakrabarti et al. 2010), increased numbers of GABAergic synapses (Nosheny et 
al. 2015), and enlargement of these synapses (Kurt et al. 2000). However, whether GABAergic 
synaptic transmission in the neocortex is increased in these mice remains to be determined. Our 
finding that the overexpressed Dscam in Ts65Dn mice increased GABAergic synaptogenesis in 
the neocortex prompted us to test this possibility.  
We examined GABAergic synaptic transmission in acute neocortical brain slices, using 
the whole-cell patch-clamp technique to record from PyNs in layers II/III of the ACC. We found 
that mIPSC frequency was increased by ~63% in Ts65Dn mice compared to euploid littermates 
(Figures 3.12E-F). These results suggest an increase in presynaptic neurotransmitter release and 
align well with our findings of enhanced synaptogenesis in ChCs and basket cells (Figures 3.7E-
G and 3.12A-D). By contrast, we found no difference in mIPSC amplitudes between euploid 
littermates and Ts65Dn mice (Figures 3.12E, G), suggesting that postsynaptic responses may not 
be affected by the trisomy. Consistent with the role of Dscam in the excessive synaptogenesis in 
Ts65Dn mice (Figures 3.8G-I), normalizing Dscam expression prevented the increase in mIPSC 
frequency in these mice (Figure 3.12E-F), suggesting that the overexpressed Dscam causes 
excessive GABAergic synaptic transmission in the Ts65Dn neocortex. Similar changes in the 
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frequency, but not amplitude, were observed in spontaneous inhibitory postsynaptic currents 
(sIPSCs) among euploid, Ts65Dn, and Ts65Dn:Dscam+/+/- mice (Figure 3.12H-J). 
Notably, normalizing Dscam levels did not rescue the increased parvalbumin-expressing 
(PV+) neuron density in the ACC region of Ts65Dn mice (Figures 3.13A-B). Consistently, the 
number of PV+ neurons was unaffected by loss of Dscam (Figures 3.13C-D). Thus, the 
overexpressed Dscam in the Ts65Dn neocortex causes excessive GABAergic synaptic 
transmission by increasing the number of GABAergic synapses without affecting the number of 
PV+ GABAergic neurons. 
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3.4 Discussion  
In this study, we provide evidence for the important role of Dscam expression levels in 
the pathogenesis of brain disorders in DS. We show that Dscam overexpression leads to 
prominent presynaptic overgrowth in ChCs and basket cells. The hyperinnervation and excessive 
GABAergic inhibition of PyNs in Ts65Dn were rescued by normalizing the Dscam levels. The 
converse phenotypes were observed in Dscam loss-of-function mutant mice. The sensitivity of 
GABAergic synapse development and function to Dscam expression levels suggest that 
dysregulated Dscam expression may underlie GABAergic dysfunction in neurological disorders 
that exhibit abnormal Dscam expression, including DS, ASDs, intractable epilepsy, bipolar 
disorders and, possibly, Fragile X syndrome. 
 
Dscam expression levels determine presynaptic terminal sizes in mammalian neurons  
The stereotypical morphology of ChCs axon arbors and presynaptic terminals are 
advantageous for quantitative assessment (Fazzari et al. 2010; Tai et al. 2014). Moreover, recent 
advances in genetic labeling of ChCs have allowed sparse labeling of single ChCs for 
quantifying presynaptic terminals at single-cell resolution (Taniguchi, Lu, and Huang 2013; 
Wang et al. 2019). By taking advantage of this system, we show in this study that Dscam 
overexpression causes presynaptic overgrowth of ChCs in the neocortex. Notably, ChC cartridge 
length and synaptogenesis are proportional to neocortical Dscam expression levels, suggesting 
the sensitivity of ChC development to Dscam levels. Thus, this work supports a conserved role 
of Dscam in regulating presynaptic terminal growth in Drosophila and mice. 
 
The coupling between presynaptic terminal growth and synaptogenesis in ChCs 
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Among the different types of GABAergic neurons, ChCs are thought to be the most 
powerful inhibitory neurons in the neocortex (DeFelipe 1999). These neurons form unique axo-
axonic GABAergic synapses that selectively innervate PyNs at their AIS, where action potentials 
are generated (Szentagothai 1975b; Jones 1975); each ChC innervates roughly two hundred 
PyNs (Blazquez-Llorca et al. 2015). Impaired ChC presynaptic growth is present in individuals 
with epilepsy and schizophrenia, both of which are thought to be caused, in part, by disrupted 
GABAergic signaling (DeFelipe 1999; Woo et al. 1998; Nakazawa et al. 2012; Lewis et al. 2012; 
Lewis 2014). Recent studies demonstrate that deleting Erbb4, a schizophrenia-associated gene, in 
ChCs causes a schizophrenia-like phenotype in mice, indicating a causal relationship between 
ChC defects and schizophrenia (Del Pino et al. 2013; Yang et al. 2018). In addition to ErbB4, 
Neuregulin 1, DOCK7, Fgf13 and L1CAM have also been found to regulate the synapse 
formation between ChCs and PyNs (Fazzari et al. 2010; Tai et al. 2014; Favuzzi et al. 2019; Tai 
et al. 2019).  
In the present study, detailed investigation of the cartridge growth and synaptogenesis at 
single-cell resolution uncovered several interesting features of ChC development. First, 
presynaptic cartridge growth is strongly associated with bouton number and, to a lesser extent, 
bouton size (Figure 3.9A-D). This observation supports the synaptotropic model proposing that 
synaptogenesis stabilizes axonal arbor growth in neurodevelopment (Cline and Haas 2008). 
Second, the factors that regulate cartridge growth and synaptogenesis are not necessarily the 
factors coupling these two processes. Although Dscam regulates both cartridge growth and 
bouton number, the coupling of these two processes remains intact in mice that are deficient of 
Dscam function, suggesting that Dscam is not the coupling factor. Identifying and distinguishing 
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coupling factors from regulators is an important step toward a mechanistic understanding of ChC 
development. 
 
Dscam overexpression leads to excessive neocortical inhibition in DS mouse model 
Overproliferation of GABAergic neurons caused by triplication of Olig1 and Olig2 
contributes to excessive GABAergic signaling in the hippocampus (Chakrabarti et al. 2010; 
Contestabile, Magara, and Cancedda 2017; Haydar and Reeves 2012). However, several lines of 
evidence suggest that heterogeneous etiology may exist in DS brain disorders such that different 
brain regions exhibit distinct molecular, cellular, and physiological defects. For example, mIPSC 
frequency is increased in the dentate gyrus, but not the CA1 region, of the hippocampus in adult 
Ts65Dn mice (Chakrabarti et al. 2010; Kleschevnikov, Belichenko, Gall, et al. 2012). In contrast 
to the large body of literature on GABAergic signaling in the hippocampus of DS animal models, 
very little is known about whether GABAergic signaling is altered in the neocortex. Previous 
studies showed that the sizes of synaptic boutons and inhibitory synapses are enlarged in the 
neocortex of Ts65Dn mice, suggesting possible alterations in GABAergic synaptic functions in 
the neocortex (Belichenko et al. 2009; Kurt et al. 2000; Belichenko et al. 2004). In the present 
study, we demonstrate that GABAergic inhibition of neocortical PyNs is excessive in Ts65Dn 
mice and that Dscam overexpression plays a key role in this process.  
Our results support the notion that alterations in GABAergic signaling in DS brains are 
region-specific. Normalizing Dscam expression reverses both increased mIPSC and sIPSC rates 
in neocortical PyNs (Figures 3.12E-J), while normalizing Olig1 and Olig2 expression 
specifically corrects sIPSC frequency in hippocampal CA1 (Chakrabarti et al. 2010). In addition, 
the effects of Dscam unlikely originate from mitotic proliferation for several reasons. Firstly, 
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Dscam is expressed in differentiating neurons but not mitotic progenitors (Yamakawa et al. 
1998; Larsen and Callaway 2006; Mayer et al. 2018; Mi et al. 2018). Secondly, our results show 
that normalizing Dscam levels does not rescue the increased density of parvalbumin-expressing 
(PV+) neurons in the ACC region of Ts65Dn mice (Figures 3.13A-B). Consistently, the number 
of cortical PV+ neurons was not affected in Dscam knock out mice (Figures 3.13C-D). 
Taken together, our findings suggest that the overexpressed Dscam in Ts65Dn mice causes 
presynaptic overgrowth and enhances neocortical GABAergic inhibition. They also suggest that 
systemic screening of hCh21 genes in Drosophila might be an effective approach to identify 
candidate genes that drive the pathogenesis of DS diseases. 
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3.5 Future directions 
Cell-autonomous function of Dscam in GABAergic neurons 
An important question is whether Dscam functions cell-autonomously to promote 
presynaptic growth in GABAergic neurons. Previous studies in Drosophila sensory neurons and 
gain-of-function studies in mouse retinal ganglion cells suggest a cell-autonomous role of Dscam 
in promoting axonal growth (Kim et al. 2013; Bruce et al. 2017). However, using Nkx2.1-CreER 
mouse line for genetic deletion of Dscam in single ChCs is challenging. Due to the weak Cre 
activity in Nkx2.1-CreER mouse line, administration of tamoxifen cannot guarantee the deletion 
of target genes in all or vast majority of cells in floxed mice. Immunostaining or in-situ 
hybridization is required to confirm the deletion. However, available anti-Dscam antibodies are 
not conducive for immunostaining in neocortices (Saito et al. 2000)(data not shown). Moreover, 
the experimental procedures for in situ hybridization are not compatible with morphological 
studies of ChCs by immunostaining.  
To address this question, one may use Lhx6-Cre, a strong mouse Cre line that targets 
both ChCs and basket cells at early developing stages (Kimura et al. 1999; Grigoriou et al. 1998; 
Del Pino et al. 2013). Crossing Lhx6-Cre with one copy of Dscam floxed mice will enable 
normalizing Dscam expression levels in GABAergic neurons in the Ts65Dn background. By 
combining immunostaining for morphological assays and patch-clamp recordings for functional 
readout, one would be able to interrogate whether Dscam cell-autonomously regulates 
synaptogenesis and synaptic transmission in GABAergic neurons.   
 
Targeting Dscam signaling for treating DS 
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This work has demonstrated a critical role of Dscam overexpression in the pathogenesis 
of the brain disorders in DS. However, Dscam encodes IgG-domain transmembrane proteins, 
which is difficult to be targeted by chemical compounds. To date, most FDA-approved chemical 
drugs target kinases to specifically inhibit their activities. In this perspective, the downstream 
effector of Dscam--Abelson tyrosine kinase (ABL)—is a promising target as FDA has approved 
multiple ABL inhibitors with high specificity and safety profiles. Particularly, our lab has shown 
that treating Drosophila larvae with ABL inhibitors rescues Dscam overexpression phenotype in 
promoting pain-sensing neuron overgrowth (Sterne, Kim, and Ye 2015a). In the future, it will be 
important to determine whether the high Dscam levels in DS mouse models cause hyperactivity 
of ABL tyrosine kinase and whether delivering ABL inhibitors, such as nilotinib, rescues the 
GABAergic dysfunctions. These studies will provide critical insights into the feasibility of post-
natal treatment of DS brain disorders with ABL inhibitors, including intellectual disability and 
hypersensitivity to pain.  
 
The role of dysregulated Dscam levels in other brain disorders 
Altered Dscam expression levels have been associated with many brain disorders, 
including DS, ASD, intractable epilepsy and bipolar disorder (Saito et al. 2000; Amano et al. 
2008; Shen et al. 2011; O'Roak et al. 2014; Krumm et al. 2015; Turner et al. 2016), and possibly 
Fragile X syndrome (Brown et al. 2001; Darnell et al. 2011; Kim et al. 2013; Cvetkovska et al. 
2013). The present work has established a causal relationship between dysregulated Dscam 
levels and the developmental and functional defects of GABAergic neurons. The dose-dependent 
function of Dscam suggests that dysregulated Dscam levels may be a common pathogenic driver 
of GABAergic dysfunctions in related neurological diseases. For example, genetic analyses have 
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revealed multiple disruptive single-nucleotide variants (SNVs) and copy number variants 
(CNVs) in Dscam gene in idiopathic ASD individuals, which raises the possibility of altered 
Dscam expression levels (Turner et al. 2016; Krumm et al. 2015; O'Roak et al. 2014; Wang et al. 
2016). Given the regulation of GABAergic signaling by Dscam levels discovered in the present 
study and the established role of impaired GABAergic signaling in ASD (Cellot and Cherubini 
2014), one may hypothesize that reduced Dscam expression causes impaired GABAergic 
signaling in ASD. In support of this, some ASD individuals with CNV of deleted enhancer 
region in Dscam show nonfebrile seizures (Turner et al. 2016), a symptom also found in mice 
with deficient Dscam function (Fuerst et al. 2008). It is thus important to examine Dscam levels 
in post-mortem samples of autistic individuals and determine whether altered Dscam expression 
causes GABAergic dysfunctions in ASD mouse models. 
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3.7 Materials and methods 
Mice breeding and tamoxifen administration 
Age-matched littermates were used for all experiments. Ts65Dn (Ts(17(16))65Dn) was 
purchased from Jackson Laboratory (Stock No: 005252) and maintained by crossing with 
C57BL/C3H F1 hybrid males.  
For labeling single ChCs in Ts65Dn mice, Ts65Dn females were crossed with Nkx2.1-CreER+/-, 
Ai14-/-, Dscam+/- male mice of mixed C57BL/C3H background to obtain euploid, Ts65Dn and 
Ts65Dn: Dscam+/+/- littermates with Nkx2.1-CreER+/-, Ai14+/- transgenes. Tamoxifen (Sigma, 
T5648-1G), dissolved in corn oil, was delivered to P0 pups by intraperitoneal injection at the 
dosage of 80 mg/kg body weight. Pseudodam was prepared in advance to lactate the pups as the 
pups were often discarded by Ts65Dn dam after the drug delivery. For labeling single ChCs in 
Dscam2j mice, female Dscam+/- mice of C3H background were crossed with Nkx2.1-CreER+/-, 
Ai14-/-, Dscam+/- male mice of mixed C57BL/C3H background to obtain Dscam+/- and Dscam-
/- pups with Nkx2.1-CreER+/-, Ai14+/- transgenes. Tamoxifen was delivered to P0 pups as 
above. Strong pups were sacrificed at P0 to keep the litter size 4-5 to increase the surviving rate 
of Dscam-/- pups. Nkx2.1-CreER+/-, Ai14-/-, Dscam+/- male mice were removed from the cage 
before female laboring as the male adults is likely to attack and sacrifice Dscam-/- pups.  
For electrophysiology recordings, Ts65Dn females were crossed with C3H Dscam+/- male mice 
to obtain euploid, Ts65Dn and Ts65Dn: Dscam+/+/- littermates. C3H Dscam+/- mice were 
interbred to obtain Dscam+/- and Dscam-/- pups for recordings.  
PCR genotyping was performed on purified tail tips at least 2 times to confirm the genotype 
according to the protocol by Jackson Laboratory. All work involving mice was approved by the 
University of Michigan Institutional Animal Care and Use Committee (IACUC) and in 
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accordance with the National Research Council Guide for the Care and Use of Laboratory 
Animals (NIH).  
 
Tissue processing 
P28 mice were euthanized by CO2 and immediately followed by intracardial infusion of 4% 
paraformaldehyde (PFA) with 4% sucrose in 1x PBS. The brains were then removed and post-
fixed in 4% PFA overnight at 4 °C, followed by incubation in 30% sucrose (wt/vol) for at least 1 
day. The brains were embedded in the OCT compound (Fisher HealthCare), frozen in -20 °C 
overnight and then sectioned to 100 μm-thick slices with a Leica CM3050S cryostat. Sectioned 
brain slices were kept in 1x PBS containing 0.05% sodium azide at 4 °C until immunostaining. 
 
Immunohistochemistry 
For ChC and AIS staining, coronal brain sections (100 μm) were blocked with 8% BSA in PBST 
(1x PBS + 0.1% Triton x-100) containing 0.05 % sodium azide at 37°C for 1 hour, and then 
incubated with the following primary antibodies in the blocking solution at 37°C overnight: anti-
mCherry (AB0081; 1:300; SICGEN) for neuronal morphology and anti-phospho-Iκβ-α (14D4 
rabbit monoclonal antibody; 1:500; Cell Signaling) for labeling the AIS. After washing 3 time (1 
hour each time) at 37°C in PBST, brain slices were incubated with the following secondary 
antibodies in the blocking solution at 37°C overnight: donkey anti-goat-rhodamine RX (RRX) 
(705-297-003; 1:300; Jackson ImmunoResearch), donkey anti-rabbit-AlexaFluor 488 (711-545-
152; 1:300; Jackson ImmunoResearch). After washing 3x for a total of 1 hour at 37°C in PBST, 
the slices were mounted in sRIMS (Yang et al. 2014). 
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The procedure for staining of GABAergic neurons and PyNs was the same as above, except that 
antibody incubations were done at room temperature and different primary antibodies were used. 
Primary antibodies used were anti-parvalbumin (PVG213; 1:1,000, Swant Inc), anti-CAMKIIα 
(6G9; 1:5,000, LSBio). Secondary antibodies used were donkey anti-goat-RRX (705-297-003; 
1:500; Jackson ImmunoResearch) and donkey anti-mouse-AlexaFluor 488 (715-545-150; 1:500; 
Jackson ImmunoResearch). 
    For staining perisomatic GABAergic synapses, antigen retrieval was conducted in 10 μM 
sodium citrate for 20 min at 95°C (Nelson et al. 2019). After a brief rinse in PBS, the slices were 
blocked in blocking buffer (1x PBS, 0.3% Triton x-100, 3% normal donkey serum, 0.05 % 
sodium azide) for 1 hour at room temperature (RT), and then incubated with the following 
primary antibodies in the blocking solution at 4°C overnight: mouse anti-Bassoon (SAP7F407; 
1:1,000; ENZO), G.P. anti-VGAT (131 004; 1:1,000; Synaptic System), rabbit anti-GRASP1 
(1:2,000) (Ye et al. 2000). After washing 3 time (20 mins each time) at RT in PBST, brain slices 
were incubated with the following secondary antibodies in the blocking solution at RT 3 hours: 
donkey anti-mouse-AlexaFluor 488 (715-545-150; 1:300; Jackson ImmunoResearch), donkey 
anti-G.P.-RRX (706-295-148; 1:300; Jackson ImmunoResearch), donkey anti-rabbit- AlexaFluor 
647 (711-605-152; 1:300; Jackson ImmunoResearch),. The slices were mounted for imaging 
after washing 3x for a total of 1 hour at RT in PBST. 
    The procedure for c-fos staining was as described previously (Flak et al. 2017). Briefly, brain 
sections were washed three times (10-min each) with 1x PBS, and then treated sequentially with 
the following solutions: 2% H2O2, 0.3% NaOH/1x PBS for 20 min, 1x PBS for 5 min twice, 
0.3% glycine/1x PBS for 10 min, 1x PBS for 5 min twice, 0.03% SDS/1x PBS for 10 min, and 
1x PBS for 5 min twice. The brain sections were then blocked in 3% normal donkey serum/0.1% 
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Triton X-100/1x PBS for 1 hr, and subsequently incubated overnight in blocking solution that 
contained anti-c-Fos antibody (#2250; 1:2000 cell signaling). The sections were washed in 1x 
PBS for three 20-min washes, and incubated with biotinylated secondary antibody (711-066-152; 
1:200; Jackson Immunoresearch) in blocking solution for 2 hours. After washing in 1x PBS for 
three 10-min washes, the sections were processed for ABC amplification (PK-6100; 1:500 in 
PBS dilution; Vector Laboratories) for 1 hour, washed in 1x PBS for 10 min three times, 
incubated in 0.05% diaminobenzidine (DAB)/0.015% H2O2/1x PBS for 3 min, and then washed 
in 1x PBS for 10 min three times. 
 
Image acquisition and quantitative analysis 
All images were acquired from layer II/III of the ACC in the mouse neocortex by using a Leica 
SP5 confocal microscope equipped with a resonant scanner, except the samples for perisomatic 
GABAergic synapses (see below). For ChCs imaging, different fluorescence channels were 
imaged sequentially with the pinhole set at airy 1. A 63x objective lens with a numerical aperture 
of 1.4 was used. Confocal image stacks were collected with 100 continuous optical sections at 
0.3-μm z-steps. The cell body was positioned around the middle of the 30-μm in depth. Before 
quantification, the image stacks were maximally projected along the z-axis. A region of 120 μm 
(length) x 80 μm (width) with the cell body in the top middle was set for quantification. 
Cartridges and boutons that colocalized with AIS were quantified by the NeuroLucida software 
(MBF Bioscience). Cartridge/bouton number was defined as the number of cartridges/boutons 
within this region. Cartridge length was defined as the distance from the first bouton that 
colocalized with AIS to the last one colocalized with AIS in that cartridge. Bouton size was 
defined as the length of the bouton in parallel to the AIS. We quantified the sizes of boutons in 
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the 10 cartridges nearest to the cell body. Interbouton distance was defined as the distance 
between two neighboring boutons.  
Samples for perisomatic GABAergic synapses were imaged on a Leica SP8 confocal microscope 
with a 63x objective lens (NA 1.4). For each PyN, a single confocal image was taken at the z-
position where PyN cell body occupied the most area. Images were deconvoluted with the 
Huygens software (Scientific Volume Imaging). Perisomatic VGAT+ and Bassoon+ puncta were 
quantified in defined PyN soma regions, as shown in Figure 6B, by the NeuroLucida software 
(MBF Bioscience).  
For c-fos and parvabumin imaging, a 20x objective lens with a NA of 1.4 was used. The z-steps 
were 1 μm. Five optical sections were maximally projected before quantification. Three fields 
were imaged for each mouse. Cells were counted in a defined area (252.4 μm × 200 μm) for each 
field manually with the assistance of the NeuroLucida software.  
To eliminate experimenter’s bias, these experiments were carried out in double-blind fashion. 
Two double-blind methods were used. First, the images acquired by the primary experimenter 
(H.L.) was coded and randomized by the second lab member (R.L. or M.V.). After the primary 
experimenter quantified the data, the data were decoded for statistical analysis. ChCs from 2 
littermates were quantified in this method. Second, the mouse brains from the primary 
experimenter (H.L.) were coded and randomized by the second lab member (R.L. or M.V.). The 
second lab member sent the encoded mouse brains to the third lab member (T.Y.) for sectioning. 
After the primary experimenter immunostained and quantified the encoded brain sections, the 
data were decoded for a final statistical analysis. ChCs from 3 littermates and the c-fos, 
parvabumin and basket cell synapse quantifications were performed in this method.  
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Western blotting 
Mouse neocortices were removed immediately after PFA perfusion. Similar volumes of tissues 
were homogenized in SDS sample buffer and loaded for electrophoresis. The proteins were 
transferred to PVDF membranes and blocked with 5% milk (wt/vol) for 1 h at room temperature. 
The blots were incubated overnight at 4 °C with goat anti Dscam (AF3666, 1:500, R&D 
systems) and mouse anti-tubulin (12G10, 1:5,000, DSHB). After washing, blots were incubated 
for 2 h with HRP-conjugated secondary antibodies and developed by chemiluminescence 
(Catalog# 32106, Pierce). Quantification was performed using ImageJ.  
 
Electrophysiology recordings and analysis  
Electrophysiological recordings of spontaneous and miniature inhibitory postsynaptic currents 
were performed as described previously (Nelson et al. 2018). Brains were obtained from euploid, 
Ts65Dn, and Ts65Dn/Dscam+/+/- mice at around P28. The animals were decapitated under 
isoflurane and USP anesthesia, and the brain was quickly removed from the skull and placed in 
4°C slicing solution containing (in mM) 62.5 NaCl, 2.5 KCl, 1.25 KH2PO4, 26 NaHCO3, 5 
MgCl2, 0.5CaCl2, 20 glucose and 100 sucrose (pH maintained at 7.4 by saturation with 95% O2 
+ 5%CO2). Coronal brain slices (300-350 µm thick) containing layers II/III of the ACC 
neocortex were cut with a microtome (VF-300, Compresstome). The slices were then transferred 
to a holding chamber and maintained at room temperature in artificial cerebrospinal fluid 
(ACSF) containing (in mM) 125 NaCl, 2.9 KCl, 1.25 KH2PO4, 26 NaHCO3, 1 MgCl2, 2 CaCl2 
and 20 glucose, pH 7.4 (with 95% O2 and 5% CO2 bubbling through the solution) for at least 1 
hour prior to recording. After equilibration, individual slices were transferred to the recording 
chamber continuously perfused with ACSF (1-2 mL/min). Recording micropipettes were pulled 
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from borosilicate glass capillaries (1.5 mm O.D. Harvard Apparatus) for a final resistance of 3-6 
MΩ and filled with a solution containing (in mM) 135 CsCl, 4 NaCl, mM GTP, Mg-ATP, 0.5 
CaCl2, 5 EGTA and 10 HEPES. The signals were recorded with an Axoclamp 700B amplifier 
(Axon Instruments, Union City, CA). Voltage clamp recordings were obtained from neurons in 
layers II/III of the ACC region; the cells in these brain regions were identified using a Nikon 
Eclipse FN-1 microscope with a 40x water-immersion objective and a DAGE MTI IR-1000 
video camera. Neurons were visualized using IR-DIC to evaluate their orientation and 
morphology. Whole-cell patch-clamp recordings for cells with a high cell resistance (greater than 
8 GΩ before break-in). sIPSC and mIPSC recordings in voltage-clamp configuration were 
acquired at 2 kHz fixing the voltage at -70 mV. The IPSCs were recorded in the presence of the 
NMDA receptor antagonist DL-2-amino-5-phosphonopentanoic acid (AP-5) at 50 mM and the 
AMPA/kainite antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) at 10 µM. For 
measurement of mIPSCs, 1 µM tetrodotoxin (TTX) was added to the perfusion solution to block 
synaptic responses dependent on the AP. Access resistance was monitored throughout the 
experiment and experiments were canceled if changes greater than 20% occurred. Peak events 
were identified automatically using Minianalysis (Synaptosoft Inc.) and visually monitored to 
exclude erroneous noise. The frequency, amplitude and distribution of events were analyzed. 
One euploid neuron (1 out of 20) with mIPSC frequency 8.9 Hz was defined as an outlier by the 
Grubbs' test and removed from quantification. Mean values were compared using the Student’s t-
test. Data are presented as mean ± SEM. 
 
Statistical analysis 
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Data are presented as mean ± SEM. Comparisons of mean differences between groups were 
performed by one way ANOVA followed by Student’s t-test. P < 0.05 was considered to be 
statistically significant. For all quantification, *: p < 0.05; **: p < 0.01; ***: p < 0.001; ns: not 
significant (p > 0.05).  
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Figure 3.1. Loss of Dscam impairs the growth of ChC axon cartridges and boutons. 
(A) A schematic of the procedure that produced the mice for the experiments. 
(B) Representative images of single ChCs in layer II/III of anterior cingulate cortex (ACC). 
Shown are ChCs of Dscam2j/+ (+/-, left) and Dscam2j/2j (-/-, right) mice at P28. All ChC images 
in this paper are from this brain region of P28 mice. Scale bar, 20 μm. 
(C-E) Quantification of axon cartridge number (C), length (D) and the total cartridge length (E). 
For each ChC, all axon cartridges (~15-40) innervating the AIS of PyNs in a volume of 120 μm 
(length) x 80 μm (width) x 30 μm (thickness) with the ChC cell body in the top middle were 
analyzed. 4-6 ChCs were analyzed for each mouse, and 4 Dscam+/- and 4 Dscam-/- mice were 
analyzed. Each dot in (C) and (E) represents one ChC. Sample numbers in (B) and (D) are 19 for 
Dscam+/- and 19 for Dscam-/-. In (D), cumulative plots show the distributions of cartridge 
length. Sample numbers are 462 for Dscam+/- and 402 for Dscam-/-. . Unless specified, mean ± 
SEM is shown in the figures, and the statistical tests are one-way ANOVA followed by Student’s 
t test. *: p < 0.05; **: p < 0.01; ***: p < 0.001; ns: not significant (p > 0.05).  
(F) Representative images of ChC axon cartridges innervating the AIS of PyNs. Cartridges of 
single ChCs were labeled with tdTomato (Red). The AIS of PyNs were labeled by anti-phospho-
IκB (pIκB, Green). The arrows point to presynaptic boutons of ChCs in the boxed regions. 
(G-H) Quantification of bouton number (G) and size (H). For each ChC, all boutons (38~194) in 
axon cartridges that innervate AIS in the defined volume (Figure S1) were analyzed for bouton 
numbers; boutons (31~84) in the 10 cartridges nearest to the cell body were analyzed for bouton 
sizes. 4-6 ChCs were analyzed in each mouse. 4 Dscam+/- and 4 Dscam-/- mice were analyzed. 
In (G), each dot represents one ChC, N: 19 for Dscam+/- and Dscam-/-. In (H), accumulative 
plots show the distributions of bouton size. N: 1079 for Dscam+/- and 1004 for Dscam-/-. 
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Figure 3.2. Quantification of ChC axon terminals and boutons. 
ChCs were sparsely labeled by tdTomato (red), and axon initial segments of PyNs were labeled 
by immunostaining with anti-phospho-IκB (Green). Confocal image stacks (0.3 μm z-steps for 
100 steps) were maximally projected along the z-axis. A region of 120 μm (length) x 80 μm 
(width) with the cell body in the top middle was quantified. Cartridges and boutons that 
colocalized with AIS were quantified. Cartridge number was defined as the number of cartridges 
within this region. Cartridge length was defined as the distance from the first to the last bouton 
that colocalizes with the AIS in that cartridge. Bouton size is defined as the length of bouton in 
parallel to AIS. Interbouton distance is defined as the distance between two neighboring boutons. 
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Figure 3.3. phospho-IκB and AnkG shows equal fidelity in labeling neocortical AIS. 
(A) AIS in layer II/III ACC was co-labeled by phospho-IκB (green) and AnkG (red). Shown are 
maximal projection of confocal image stacks (1 μm z-steps X 7 steps).  
(B) Quantification of the percentage of AIS that is labeled by phospho-IκB and/or AnkG. 308 
AIS were quantified, among which 303 were co-labeled by phospho-IκB and AnkG. 
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Figure 3.4. Dscam does not regulate bouton density.  
For each ChC, all boutons (38~194) in axon cartridges that innervate AIS in the defined volume 
were analyzed for bouton density (indicated by interbouton distance); 4-6 ChCs were analyzed 
for each mouse. The accumulative plots show the distributions of bouton density. (A) 4 
Dscam+/- and 4 Dscam-/- mice were analyzed. n: 2073 for Dscam+/- and 1640 for Dscam-/-. (B) 
4 euploid, 5 Ts65Dn, and 4 Ts65Dn:Dscam+/+/- mice were analyzed. n: 2214 for euploid, 3189 
for Ts65Dn and 1912 for Ts65Dn:Dscam+/+/-. 
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Figure 3.5. Loss of Dscam impairs GABAergic inhibition of neocortical PyNs. 
(A) Representative traces of mIPSCs from PyNs in layer II/III of ACC in Dscam+/- and Dscam-
/- brain slices. 
(B-C) Quantification of mIPSC frequency (B) and amplitude (C). 3-5 PyNs were recorded for 
each mouse. 5 Dscam+/- and 4 Dscam-/- mice were analyzed. N: 16 for Dscam+/-, and 13 for 
Dscam-/-.  
(D) Representative traces of sIPSCs from PyNs in layer II/III of ACC in Dscam+/- and Dscam-/- 
brain slices.  
(E-F) Quantification of sIPSC frequency (E) and amplitude (F). 3~5 PyNs were recorded for 
each mouse. 5 Dscam+/- and 4 Dscam-/- mice were analyzed. N: 17 for Dscam+/-, 14 for 
Dscam-/-.  
(G) Representative images of c-fos levels in Dscam+/- and Dscam-/- mice. C-fos levels reflect 
neuronal activity. Anti-CaMKIIα immunostaining marks PyNs. The red arrowheads point to the 
PyNs with detectable c-fos immunostaining. Images were acquired from layer II/III of the ACC 
at P28.  
(H) c-fos levels are increased in Dscam-/- mice. The graph shows the percentage of the 
percentage of c-fos-positive PyNs in total PyNs. Each dot represents the value in one randomly 
selected field for imaging. Three fields were imaged in each mouse. 4 Dscam+/- and 4 Dscam-/- 
mice were analyzed. 
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Figure 3.6. Dscam expression level is increased in Ts65Dn neocortices. 
Representative western blots (A) and quantifications (B) of neocortical samples from euploid, 
Ts65Dn mice. Sample numbers are n=7 for euploid, 9 for Ts65Dn. 
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Figure 3.7. ChC axonal terminals and presynaptic boutons are overgrown in Ts65Dn mice. 
(A) Representative images of single ChCs in wild-type (euploid, left) and Ts65Dn (right) mice at 
P28. Scale bar, 20 μm. 
(B-D) Quantification of axon cartridge number (B), length (C) and the total cartridge length (D). 
Each dot in (B) and (D) represents one ChC. Sample number (n): 21 for euploid and 26 for 
Ts65Dn. In (C), cumulative plots show the distributions of cartridge length, n=452 for euploid, 
717 for Ts65Dn. Sample numbers are shown in the figure.  
(E) Representative images of ChC axon cartridges innervating the AIS of PyNs. Cartridges of 
single ChCs were labeled with tdTomato. The AIS of PyNs were labeled by anti-phospho-IκB 
(pIκB). The arrows point to presynaptic boutons of ChCs in the boxed regions.  
(F-G) Quantification of bouton number (F) and size (G). 4-6 ChCs were analyzed for each 
mouse. 4 euploid and 5 Ts65Dn mice were analyzed. In (F), each dot represents one ChC, N: 21 
for euploid and 26 for Ts65Dn. In (G), accumulative plots show the distributions of bouton size, 
n=1149 for euploid, 1655 for Ts65Dn. 
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Figure 3.8. Normalizing Dscam expression rescues the overgrowth of ChC axon cartridges 
and presynaptic boutons in Ts65Dn mice. 
(A) A schematic of the procedure that produced the mice for the experiments. 
(B) Dscam overexpression is normalized to the euploid level in Ts65Dn mice by introducing one 
Dscam mutant allele. Shown are representative western blots (top) and quantifications (bottom) 
of neocortical samples from euploid, Ts65Dn, and Ts65Dn:Dscam+/+/-. Sample numbers are 
indicated in the bars. 
(C) Representative images of single ChCs in layer II/III of the ACC. Shown are ChCs of Ts65Dn 
(left) and Ts65Dn with Dscam allele normalized (Ts65Dn:Dscam+/+/-, right) mice at P28. Scale 
bar, 20 μm. 
(D-F) Quantification of axon cartridge number (D), length (E) and the total cartridge length (F). 
4-6 ChCs were analyzed for each mouse; 4 euploid, 5 Ts65Dn, and 4 Ts65Dn:Dscam+/+/- mice 
were analyzed. Sample numbers are 21 for euploid, 26 for Ts65Dn, and 21 for 
Ts65Dn:Dscam+/+/- in (D) and (F). In (E), n=452 for euploid, 717 for Ts65Dn and 491 for 
Ts65Dn:Dscam+/+/-.  
(G) Representative images of ChC cartridges innervating the AIS of PyNs. The arrows point to 
presynaptic boutons of ChCs in the boxed region.  
(H-I) Quantification of bouton number (H) and size (I). 4-6 ChCs were analyzed for each mouse, 
and 4 euploid, 5 Ts65Dn, and 4 Ts65Dn:Dscam+/+/- mice were analyzed. In (H), each dot 
represents one ChC, N: 21 for euploid, 26 for Ts65Dn, and 21 for Ts65Dn:Dscam+/+/-. In (I), 
accumulative plots show the distributions of bouton size, n=1149 for euploid, 1655 for Ts65Dn 
and 1209 for Ts65Dn:Dscam+/+/-. 
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Figure 3.9. Coupling between presynaptic terminal growth and synaptogenesis in ChC 
development.  
(A) ChC cartridge length and bouton number are strongly correlated in both euploid and Ts65Dn 
genetic backgrounds. Each dot presents one ChC. 4-6 ChCs were analyzed for each mouse. 4 
euploid, 5 Ts65Dn, 4 Ts65Dn:Dscam+/+/- mice were analyzed. n=21 for euploid (gray dots), 26 
for Ts65Dn (blue dots), 21 Ts65Dn:Dscam+/+/- (coral dots). R2 and p are calculated for linear 
regression. The gray line indicates the trend line for gray dots, while the black line is that for 
blue and coral dots. 
(B) ChC cartridge length and bouton number are strongly correlated in Dscam+/- and Dscam-/- 
mice. Each dot presents one ChC. 4–6 ChCs were analyzed for each mouse. 4 Dscam+/- and 4 
Dscam-/- mice were analyzed. N: 19 for Dscam+/- (gray dots) and 19 for Dscam-/- (coral dots).  
(C) ChC cartridge length and bouton size show weak, yet significant, correlation in euploid and 
Ts65Dn background. Each dot presents one ChC.  
(D) The correlation between cartridge length and bouton number is impaired in Dscam-/- mice. 
Each dot presents one ChC. R2 is small in both Dscam+/- and Dscam-/- mice, suggesting that 
linear regression only explains a small fraction of the samples. The correction is insignificant in 
Dscam-/- mice (p > 0.05).  
(E-F) ChC cartridge length and interbouton distance shows no significant correlation between 
any two genotypes tested. Each dot presents one ChC. 
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Figure 3.10. Dscam regulates ChC cartridge length and synaptogenesis in a dosage-
dependent manner. 
(A) Western blots showing Dscam levels in the neocortex. The mouse neocortex was taken 
immediately after perfusion. 
(B-E) The correlation analyses between Dscam expression level and ChC cartridge length (B), 
bouton number (C), bouton size (D) or interbouton distance (E). In (B), the Dscam level of a 
mouse is plotted against the mean of the total cartridge length in the volume specified in 
Supplementary Fig. 1 in this mouse. The average cartridge length is the calculated as the average 
value of 4-6 ChCs sampled in each mouse. 4 euploid, 5 Ts65Dn, and 4 Ts65Dn:Dscam+/+/- 
mice were analyzed. N: 21 euploid (black dots), 26 Ts65Dn (red dots), and 21 
Ts65Dn:Dscam+/+/- (green dots). R2 and p are calculated for linear regression.  
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Figure 3.11. Quantification of perisomatic GABAergic synapses on PyNs. 
(A) Representative confocal image of a PyN in layer II/III in the ACC. The soma is labeled by 
anti-GRASP1 (blue). The presynaptic active zones are labeled by anti-Bassoon (green). The 
GABA vesicles in presynaptic terminals of GABAergic neurons are labeled by anti-VGAT (red). 
The perisomatic Bassoon+ puncta that are apposed to or overlap with VGAT+ puncta were 
quantified as GABAergic synapses (yellow arrowhead). The green arrowhead indicates the 
VGAT-independent perisomatic Bassoon+ puncta.  
(B) To define the soma region for quantifying perisomatic GABAergic synapses, we drew a line 
that is both perpendicular to the apical dendrite and tangent to the edge of the PyN nucleus, and 
then quantified GABAergic synapses in the GRASP1+ area below the line. 
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Figure 3.12. Normalizing Dscam levels rescues the increased synaptogenesis in basket cells 
and the enhanced GABAergic synaptic transmission in Ts65Dn neocortex. 
(A-C) Representative images of perisomatic GABAergic synapses innervating PyNs in layer 
II/III ACC of euploid (wild-type), Ts65Dn, and Ts65Dn:Dscam+/+/-. Scale bar, 5 μm. Right 
side is the magnified views of the regions boxed by dotted lines. Scale bar, 1 μm. The soma and 
proximal dendrites of PyNs were labeled by GRASP1. Yellow arrow head point to GABAergic 
synapses as indicated by Bassoon+ puncta that are either apposed to or overlapped with VGAT+ 
puncta. 
(D) Quantification of the number of perisomatic GABAergic synapses per PyN. 5-7 PyNs were 
analyzed for each mouse; 4 euploid, 5 Ts65Dn, and 4 Ts65Dn:Dscam+/+/- mice were analyzed. 
Sample numbers are 24 for euploid, 29 for Ts65Dn, and 23 for Ts65Dn:Dscam+/+/-. 
(E) Representative traces of mIPSCs from PyNs in layer II/III of ACC in euploid, Ts65Dn, and 
Ts65Dn:Dscam+/+/- brain slices.  
(F-G) Quantification of mIPSC frequency (F) and amplitude (G). 2-4 PyNs were recorded for 
each mouse. 6 euploid control, 6 Ts65Dn, and 6 Ts65Dn:Dscam+/+/- were analyzed. N: 15 for 
euploid, 13 for Ts65Dn, and 14 Ts65Dn:Dscam+/+/-.  
(H) Representative traces of sIPSCs from PyNs in layer II/III of ACC in euploid, Ts65Dn and 
Ts65Dn:Dscam+/+/- brain slices.  
(I-J) Quantification of sIPSC frequency (I) and amplitude (J). 2~4 PyNs were recorded for each 
mouse. 6 euploid, 7 Ts65Dn, and 6 Ts65Dn:Dscam+/+/- mice were analyzed. N: 19 for euploid, 
19 for Ts65Dn, and 16 Ts65Dn:Dscam+/+/-. 
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Figure 3.13. Dscam does not regulate the number of GABAergic neurons in the neocortex.  
(A-B) Dscam overexpression in Ts65Dn mice does not affect the number of GABAergic neurons 
in the neocortex. Brain sections from P28 mice were immunostained with anti-parvalbumin 
(PV). Representative images are shown in (A), and quantifications of the density of PV+ neurons 
are shown in (B). Each dot represents the value from one imaging field that is 252.4 μm (width) 
x 200 μm (length) x 5 μm (thickness). Images were collected from layer II/III of the ACC. Three 
fields in each mouse were randomly selected for imaging. 5 euploid, 6 Ts65Dn, and 5 
Ts65Dn:Dscam+/+/- mice were analyzed.  
(C-D) Loss of Dscam does not affect the number of GABAergic neurons in the ACC. 
Representative images and quantifications are shown in (C) and (D), respectively. 4 Dscam+/- 
and 4 Dscam-/- mice were analyzed. 
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